| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.996 | 0 | 1 | Vasodilator | 1 0 DBMET01480 1 0 DB12529 0.784 0.003 DB13526 | DB12529 | |
| 0.989 | 0 | 0.999 | Nitric oxide donor | 0.071 0.032 DBMET01480 0.999 0 DB12529 0.089 0.015 DB13526 | DB12529 | |
| 0.951 | 0.004 | 0.951 | Antiinflammatory | 0.852 0.009 DB12529 0.457 0.107 DB13526 | ||
| 0.914 | 0.002 | 0.914 | Cyclooxygenase 1 inhibitor | |||
| 0.902 | 0.003 | 0.902 | Platelet antagonist | 0.222 0.087 DB12529 0.268 0.065 DB13526 | ||
| 0.876 | 0.003 | 0.876 | Cyclooxygenase inhibitor | |||
| 0.875 | 0.005 | 0.999 | Analgesic | 0.999 0 DB12529 | DB12529 | |
| 0.85 | 0.002 | 0.85 | Cyclooxygenase 2 inhibitor | |||
| 0.77 | 0.004 | 0.77 | Platelet aggregation inhibitor | |||
| 0.755 | 0.003 | 0.755 | Platelet adhesion inhibitor | |||
| 0.727 | 0.004 | 0.727 | Vasodilator, coronary | 0.512 0.014 DBMET01480 0.434 0.026 DB12529 0.498 0.016 DB13526 | ||
| 0.729 | 0.026 | 0.729 | Apoptosis agonist | 0.238 0.227 DB13526 | ||
| 0.699 | 0.006 | 0.699 | Spasmolytic | 0.31 0.066 DB12529 0.45 0.031 DB13526 | ||
| 0.693 | 0.005 | 0.693 | Cardiotonic | |||
| 0.679 | 0.001 | 0.679 | Guanylate cyclase stimulant | 0.059 0.014 DB13526 | ||
| 0.674 | 0.003 | 0.674 | Butyrylcholinesterase inhibitor | |||
| 0.663 | 0.005 | 0.663 | Hypoglycemic | 0.376 0.032 DB13526 | ||
| 0.647 | 0.005 | 0.647 | Angiogenesis stimulant | 0.298 0.05 DB13526 | ||
| 0.644 | 0.011 | 0.644 | Vasodilator, peripheral | 0.303 0.095 DBMET01480 0.303 0.095 DB12529 0.415 0.05 DB13526 | ||
| 0.631 | 0.007 | 0.631 | Free radical scavenger | 0.287 0.055 DB13526 | ||
| 0.631 | 0.015 | 0.631 | Cholesterol antagonist | 0.328 0.075 DBMET01480 0.328 0.075 DB12529 0.621 0.016 DB13526 | ||
| 0.559 | 0.014 | 0.559 | Antioxidant | 0.377 0.039 DB13526 | ||
| 0.516 | 0.007 | 0.516 | Anesthetic general | 0.25 0.05 DBMET01480 0.25 0.05 DB12529 0.42 0.014 DB13526 | ||
| 0.513 | 0.006 | 0.513 | Hepatoprotectant | 0.141 0.119 DB13526 | ||
| 0.504 | 0.006 | 0.504 | Cholinergic | |||
| 0.501 | 0.005 | 0.501 | Acetylcholinesterase inhibitor | |||
| 0.516 | 0.022 | 0.587 | GABA C receptor rho-3 antagonist | 0.587 0.009 DBMET01480 0.587 0.009 DB12529 0.573 0.011 DB13526 | DB12529 | |
| 0.493 | 0.005 | 0.493 | Calcium channel activator | 0.396 0.026 DBMET01480 0.396 0.026 DB12529 0.377 0.034 DB13526 | ||
| 0.409 | 0.003 | 0.691 | ErbB-3 antagonist | 0.691 0.002 DB13526 | DB13526 | |
| 0.416 | 0.02 | 0.416 | DNA synthesis inhibitor | 0.298 0.044 DBMET01480 0.298 0.044 DB12529 0.408 0.02 DB13526 | ||
| 0.391 | 0.009 | 0.786 | Alpha-N-acetylglucosaminidase inhibitor | 0.583 0.004 DBMET01480 0.583 0.004 DB12529 0.786 0.002 DB13526 | DB13526 | |
| 0.445 | 0.065 | 0.512 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.512 0.029 DBMET01480 0.512 0.029 DB12529 0.504 0.032 DB13526 | DB12529 | |
| 0.381 | 0.007 | 0.381 | Insulin secretagoues | 0.296 0.013 DB13526 | ||
| 0.37 | 0.002 | 0.37 | Guanylate cyclase 1 stimulant | 0.029 0.007 DB13526 | ||
| 0.393 | 0.026 | 0.766 | Hypolipemic | 0.766 0.004 DB13526 | DB13526 | |
| 0.335 | 0.014 | 0.335 | Lipid peroxidase inhibitor | |||
| 0.276 | 0.005 | 0.276 | CF transmembrane conductance regulator agonist | 0.193 0.026 DBMET01480 0.193 0.026 DB12529 0.184 0.033 DB13526 | ||
| 0.297 | 0.029 | 0.297 | Non-steroidal antiinflammatory agent | 0.182 0.086 DB13526 | ||
| 0.382 | 0.122 | 0.563 | Caspase 9 stimulant | 0.481 0.068 DBMET01480 0.481 0.068 DB12529 0.563 0.042 DB13526 | DB13526 | |
| 0.262 | 0.008 | 0.262 | Cyclooxygenase 3 inhibitor | 0.161 0.039 DBMET01480 0.161 0.039 DB12529 0.184 0.025 DB13526 | ||
| 0.262 | 0.012 | 0.492 | GABA C receptor agonist | 0.466 0.004 DBMET01480 0.466 0.004 DB12529 0.492 0.004 DB13526 | DB13526 | |
| 0.264 | 0.015 | 0.264 | Calcium channel blocker | |||
| 0.285 | 0.041 | 0.404 | Tyrosine 3 hydroxylase inhibitor | 0.404 0.008 DBMET01480 0.404 0.008 DB12529 0.386 0.01 DB13526 | DB12529 | |
| 0.303 | 0.065 | 0.784 | Aldehyde oxidase inhibitor | 0.507 0.032 DBMET01480 0.507 0.032 DB12529 0.784 0.005 DB13526 | DB13526 | |
| 0.237 | 0.009 | 0.237 | Calcium antagonist | 0.116 0.037 DBMET01480 0.116 0.037 DB12529 0.115 0.038 DB13526 | ||
| 0.231 | 0.006 | 0.231 | Aldose reductase inhibitor | |||
| 0.278 | 0.058 | 0.4 | 5 Hydroxytryptamine uptake stimulant | 0.4 0.014 DBMET01480 0.4 0.014 DB12529 0.37 0.02 DB13526 | DB12529 | |
| 0.244 | 0.024 | 0.44 | Succinate dehydrogenase inhibitor | 0.31 0.009 DBMET01480 0.31 0.009 DB12529 0.44 0.004 DB13526 | DB13526 | |
| 0.224 | 0.005 | 0.224 | Leukotriene synthesis inhibitor | |||
| 0.332 | 0.131 | 0.585 | 5 Hydroxytryptamine release inhibitor | 0.453 0.05 DBMET01480 0.453 0.05 DB12529 0.585 0.013 DB13526 | DB13526 | |
| 0.24 | 0.04 | 0.303 | Nitric-oxide synthase stimulant | 0.303 0.011 DBMET01480 0.303 0.011 DB12529 0.28 0.017 DB13526 | DB12529 | |
| 0.291 | 0.091 | 0.291 | Apoptosis antagonist | |||
| 0.288 | 0.097 | 0.29 | Antithrombotic | 0.207 0.169 DBMET01480 0.207 0.169 DB12529 0.29 0.095 DB13526 | DB13526 | |
| 0.208 | 0.017 | 0.407 | UDP-glucose 4-epimerase inhibitor | 0.342 0.008 DBMET01480 0.342 0.008 DB12529 0.407 0.005 DB13526 | DB13526 | |
| 0.221 | 0.035 | 0.268 | 5 Hydroxytryptamine 3E antagonist | 0.268 0.01 DBMET01480 0.268 0.01 DB12529 0.244 0.019 DB13526 | DB12529 | |
| 0.265 | 0.082 | 0.563 | 5 Hydroxytryptamine release stimulant | 0.508 0.026 DBMET01480 0.508 0.026 DB12529 0.563 0.018 DB13526 | DB13526 | |
| 0.189 | 0.012 | 0.432 | Triose-phosphate isomerase inhibitor | 0.301 0.005 DBMET01480 0.301 0.005 DB12529 0.432 0.003 DB13526 | DB13526 | |
| 0.197 | 0.031 | 0.261 | GABA C receptor rho-2 antagonist | 0.248 0.012 DBMET01480 0.248 0.012 DB12529 0.261 0.01 DB13526 | DB13526 | |
| 0.199 | 0.034 | 0.246 | Arachidonic acid antagonist | 0.214 0.021 DBMET01480 0.214 0.021 DB12529 0.246 0.006 DB13526 | DB13526 | |
| 0.183 | 0.018 | 0.313 | Adenylate kinase inhibitor | 0.279 0.008 DBMET01480 0.279 0.008 DB12529 0.313 0.006 DB13526 | DB13526 | |
| 0.219 | 0.055 | 0.222 | Insulin sensitizer | 0.162 0.117 DBMET01480 0.162 0.117 DB12529 0.222 0.053 DB13526 | DB13526 | |
| 0.168 | 0.005 | 0.168 | Caspase 9 inhibitor | |||
| 0.185 | 0.026 | 0.381 | Ferrochelatase inhibitor | 0.356 0.004 DBMET01480 0.356 0.004 DB12529 0.381 0.004 DB13526 | DB13526 | |
| 0.239 | 0.082 | 0.51 | Superoxide dismutase inhibitor | 0.391 0.028 DBMET01480 0.391 0.028 DB12529 0.51 0.012 DB13526 | DB13526 | |
| 0.174 | 0.02 | 0.287 | GABA C receptor antagonist | 0.232 0.008 DBMET01480 0.232 0.008 DB12529 0.287 0.005 DB13526 | DB13526 | |
| 0.164 | 0.015 | 0.164 | Potassium channel activator | 0.087 0.064 DB13526 | ||
| 0.157 | 0.015 | 0.157 | Carbonic anhydrase inhibitor | |||
| 0.162 | 0.021 | 0.2 | Ca2+-transporting ATPase inhibitor | 0.187 0.005 DBMET01480 0.187 0.005 DB12529 0.2 0.004 DB13526 | DB13526 | |
| 0.159 | 0.024 | 0.341 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.289 0.007 DBMET01480 0.289 0.007 DB12529 0.341 0.005 DB13526 | DB13526 | |
| 0.151 | 0.018 | 0.301 | Phosphofructokinase-1 inhibitor | 0.213 0.01 DBMET01480 0.213 0.01 DB12529 0.301 0.005 DB13526 | DB13526 | |
| 0.151 | 0.021 | 0.204 | DOPA decarboxylase inhibitor | 0.185 0.009 DBMET01480 0.185 0.009 DB12529 0.204 0.006 DB13526 | DB13526 | |
| 0.191 | 0.062 | 0.559 | Peroxidase inhibitor | 0.441 0.015 DBMET01480 0.441 0.015 DB12529 0.559 0.005 DB13526 | DB13526 | |
| 0.141 | 0.012 | 0.325 | Carbamoyl phosphate synthetase inhibitor | 0.184 0.008 DBMET01480 0.184 0.008 DB12529 0.325 0.004 DB13526 | DB13526 | |
| 0.212 | 0.084 | 0.343 | RNA-directed DNA polymerase inhibitor | 0.29 0.034 DBMET01480 0.29 0.034 DB12529 0.343 0.025 DB13526 | DB13526 | |
| 0.137 | 0.012 | 0.137 | Calcium channel L-type blocker | |||
| 0.16 | 0.038 | 0.16 | DNA intercalator | 0.09 0.086 DB13526 | ||
| 0.195 | 0.076 | 0.305 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.284 0.029 DBMET01480 0.284 0.029 DB12529 0.305 0.022 DB13526 | DB13526 | |
| 0.131 | 0.012 | 0.781 | Alcohol oxidase inhibitor | 0.332 0.004 DBMET01480 0.332 0.004 DB12529 0.781 0.003 DB13526 | DB13526 | |
| 0.127 | 0.012 | 0.227 | Acyl-CoA dehydrogenase inhibitor | 0.172 0.007 DBMET01480 0.172 0.007 DB12529 0.227 0.004 DB13526 | DB13526 | |
| 0.135 | 0.022 | 0.339 | NADH dehydrogenase inhibitor | 0.222 0.009 DBMET01480 0.222 0.009 DB12529 0.339 0.006 DB13526 | DB13526 | |
| 0.153 | 0.045 | 0.209 | Alkylator | 0.12 0.068 DBMET01480 0.12 0.068 DB12529 0.209 0.024 DB13526 | DB13526 | |
| 0.132 | 0.031 | 0.217 | GABA C receptor rho-1 antagonist | 0.202 0.008 DBMET01480 0.202 0.008 DB12529 0.217 0.006 DB13526 | DB13526 | |
| 0.133 | 0.032 | 0.287 | Creatine kinase inhibitor | 0.217 0.008 DBMET01480 0.217 0.008 DB12529 0.287 0.004 DB13526 | DB13526 | |
| 0.155 | 0.055 | 0.224 | Adenylate cyclase stimulant | 0.185 0.022 DBMET01480 0.185 0.022 DB12529 0.224 0.006 DB13526 | DB13526 | |
| 0.163 | 0.066 | 0.222 | Diuretic | 0.222 0.037 DB12529 0.157 0.071 DB13526 | DB12529 | |
| 0.129 | 0.033 | 0.129 | Nitric-oxide synthase inhibitor | 0.094 0.07 DBMET01480 0.094 0.07 DB12529 0.114 0.042 DB13526 | ||
| 0.099 | 0.005 | 0.099 | Potassium channel (Inward rectifier) activator | 0.064 0.016 DBMET01480 0.064 0.016 DB12529 0.051 0.033 DB13526 | ||
| 0.103 | 0.009 | 0.103 | Phosphodiesterase 1C inhibitor | 0.066 0.036 DB13526 | ||
| 0.1 | 0.007 | 0.373 | 5 Hydroxytryptamine 1B agonist | 0.373 0.003 DB13526 | DB13526 | |
| 0.108 | 0.016 | 0.218 | Biliverdin reductase inhibitor | 0.211 0.005 DBMET01480 0.211 0.005 DB12529 0.218 0.005 DB13526 | DB13526 | |
| 0.096 | 0.005 | 0.096 | Potassium channel (ATP-sensitive) activator | 0.061 0.015 DBMET01480 0.061 0.015 DB12529 0.049 0.032 DB13526 | ||
| 0.1 | 0.01 | 0.1 | Phosphodiesterase 1A inhibitor | 0.057 0.049 DBMET01480 0.057 0.049 DB12529 0.056 0.052 DB13526 | ||
| 0.122 | 0.037 | 0.156 | Anabolic | 0.145 0.021 DBMET01480 0.145 0.021 DB12529 0.156 0.015 DB13526 | DB13526 | |
| 0.273 | 0.188 | 0.429 | Cyclophilin D inhibitor | 0.429 0.076 DB13526 | DB13526 | |
| 0.1 | 0.017 | 0.1 | Beta adrenoreceptor antagonist | 0.074 0.033 DB13526 | ||
| 0.097 | 0.016 | 0.097 | Alpha 2 adrenoreceptor agonist | |||
| 0.103 | 0.026 | 0.167 | Thioredoxin reductase inhibitor | 0.167 0.007 DB13526 | DB13526 | |
| 0.105 | 0.027 | 0.219 | Glutamate decarboxylase inhibitor | 0.167 0.01 DBMET01480 0.167 0.01 DB12529 0.219 0.005 DB13526 | DB13526 | |
| 0.125 | 0.05 | 0.204 | Aminopeptidase B inhibitor | 0.183 0.026 DBMET01480 0.183 0.026 DB12529 0.204 0.02 DB13526 | DB13526 | |
| 0.098 | 0.022 | 0.192 | Glycine receptor agonist | 0.111 0.015 DBMET01480 0.111 0.015 DB12529 0.192 0.004 DB13526 | DB13526 | |
| 0.082 | 0.008 | 0.164 | Glucose-6-phosphate isomerase inhibitor | 0.105 0.004 DBMET01480 0.105 0.004 DB12529 0.164 0.002 DB13526 | DB13526 | |
| 0.087 | 0.014 | 0.087 | Beta 1 adrenoreceptor antagonist | 0.068 0.028 DB13526 | ||
| 0.089 | 0.017 | 0.238 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.139 0.009 DBMET01480 0.139 0.009 DB12529 0.238 0.005 DB13526 | DB13526 | |
| 0.105 | 0.034 | 0.281 | Porphobilinogen synthase inhibitor | 0.281 0.006 DBMET01480 0.281 0.006 DB12529 0.272 0.006 DB13526 | DB12529 | |
| 0.101 | 0.031 | 0.119 | Na+ K+ transporting ATPase inhibitor | 0.105 0.027 DBMET01480 0.105 0.027 DB12529 0.119 0.017 DB13526 | DB13526 | |
| 0.106 | 0.038 | 0.106 | Phosphodiesterase I inhibitor | 0.08 0.076 DB13526 | ||
| 0.148 | 0.08 | 0.25 | Interferon gamma antagonist | 0.177 0.052 DBMET01480 0.177 0.052 DB12529 0.25 0.028 DB13526 | DB13526 | |
| 0.123 | 0.056 | 0.233 | Cystathionine beta-synthase inhibitor | 0.194 0.026 DBMET01480 0.194 0.026 DB12529 0.233 0.018 DB13526 | DB13526 | |
| 0.097 | 0.032 | 0.201 | Glutamate dehydrogenase inhibitor | 0.181 0.012 DBMET01480 0.181 0.012 DB12529 0.201 0.01 DB13526 | DB13526 | |
| 0.085 | 0.02 | 0.085 | Phosphodiesterase 1B inhibitor | |||
| 0.085 | 0.023 | 0.085 | Carbonic anhydrase II inhibitor | |||
| 0.113 | 0.051 | 0.113 | Xanthine oxidase inhibitor | 0.085 0.08 DBMET01480 0.085 0.08 DB12529 0.103 0.057 DB13526 | ||
| 0.083 | 0.021 | 0.125 | Glutamate (mGluR6) antagonist | 0.103 0.009 DBMET01480 0.103 0.009 DB12529 0.125 0.005 DB13526 | DB13526 | |
| 0.097 | 0.039 | 0.137 | Granulocyte macrophage colony stimulating factor agonist | 0.13 0.011 DBMET01480 0.13 0.011 DB12529 0.137 0.008 DB13526 | DB13526 | |
| 0.128 | 0.07 | 0.186 | Vanilloid 1 agonist | 0.133 0.061 DBMET01480 0.133 0.061 DB12529 0.186 0.016 DB13526 | DB13526 | |
| 0.092 | 0.036 | 0.148 | Estrogen-related receptor beta agonist | 0.107 0.018 DBMET01480 0.107 0.018 DB12529 0.148 0.004 DB13526 | DB13526 | |
| 0.079 | 0.025 | 0.079 | Carbonic anhydrase I inhibitor | |||
| 0.12 | 0.067 | 0.233 | Topoisomerase II inhibitor | 0.233 0.027 DB13526 | DB13526 | |
| 0.153 | 0.1 | 0.295 | Phospholipase C inhibitor | 0.188 0.053 DBMET01480 0.188 0.053 DB12529 0.295 0.019 DB13526 | DB13526 | |
| 0.113 | 0.06 | 0.145 | Acetylcholine release stimulant | 0.143 0.021 DBMET01480 0.143 0.021 DB12529 0.145 0.02 DB13526 | DB13526 | |
| 0.133 | 0.081 | 0.241 | Mannose-6-phosphate isomerase inhibitor | 0.221 0.021 DBMET01480 0.221 0.021 DB12529 0.241 0.014 DB13526 | DB13526 | |
| 0.076 | 0.024 | 0.095 | Carbonic anhydrase VB inhibitor | 0.075 0.025 DBMET01480 0.075 0.025 DB12529 0.095 0.017 DB13526 | DB13526 | |
| 0.067 | 0.016 | 0.067 | Carbonic anhydrase IV inhibitor | |||
| 0.069 | 0.019 | 0.17 | Aconitate hydratase inhibitor | 0.127 0.005 DBMET01480 0.127 0.005 DB12529 0.17 0.004 DB13526 | DB13526 | |
| 0.087 | 0.038 | 0.2 | Histidine decarboxylase inhibitor | 0.192 0.014 DBMET01480 0.192 0.014 DB12529 0.2 0.013 DB13526 | DB13526 | |
| 0.073 | 0.024 | 0.073 | Phosphodiesterase 4C inhibitor | |||
| 0.136 | 0.088 | 0.197 | Sphingosine 1-phosphate receptor 5 antagonist | 0.167 0.037 DBMET01480 0.167 0.037 DB12529 0.197 0.013 DB13526 | DB13526 | |
| 0.067 | 0.019 | 0.148 | Alpha-mannosidase inhibitor | 0.084 0.01 DBMET01480 0.084 0.01 DB12529 0.148 0.004 DB13526 | DB13526 | |
| 0.088 | 0.045 | 0.125 | Glycine receptor antagonist | 0.125 0.015 DBMET01480 0.125 0.015 DB12529 0.125 0.015 DB13526 | DB13526 | |
| 0.081 | 0.037 | 0.081 | Alpha adrenoreceptor agonist | |||
| 0.111 | 0.069 | 0.111 | Calcium channel (voltage-sensitive) blocker | |||
| 0.07 | 0.03 | 0.167 | Argininosuccinate synthase inhibitor | 0.167 0.01 DBMET01480 0.167 0.01 DB12529 0.164 0.01 DB13526 | DB12529 | |
| 0.081 | 0.041 | 0.171 | Aminopeptidase I inhibitor | 0.126 0.018 DBMET01480 0.126 0.018 DB12529 0.171 0.009 DB13526 | DB13526 | |
| 0.083 | 0.045 | 0.224 | Keratolytic | 0.092 0.036 DBMET01480 0.092 0.036 DB12529 0.224 0.006 DB13526 | DB13526 | |
| 0.066 | 0.028 | 0.167 | Ornithine carbamoyltransferase inhibitor | 0.11 0.014 DBMET01480 0.11 0.014 DB12529 0.167 0.008 DB13526 | DB13526 | |
| 0.088 | 0.051 | 0.408 | Vanilloid agonist | 0.408 0.004 DB13526 | DB13526 | |
| 0.062 | 0.025 | 0.086 | Pregnane X receptor antagonist | 0.076 0.009 DBMET01480 0.076 0.009 DB12529 0.086 0.005 DB13526 | DB13526 | |
| 0.05 | 0.014 | 0.069 | Kainate receptor agonist | 0.067 0.005 DBMET01480 0.067 0.005 DB12529 0.069 0.005 DB13526 | DB13526 | |
| 0.056 | 0.02 | 0.138 | Mannosidase inhibitor | 0.073 0.011 DBMET01480 0.073 0.011 DB12529 0.138 0.004 DB13526 | DB13526 | |
| 0.078 | 0.042 | 0.11 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.11 0.009 DBMET01480 0.11 0.009 DB12529 0.09 0.022 DB13526 | DB12529 | |
| 0.059 | 0.023 | 0.083 | Lysophosphatidic acid 3 receptor antagonist | 0.068 0.015 DBMET01480 0.068 0.015 DB12529 0.083 0.008 DB13526 | DB13526 | |
| 0.097 | 0.062 | 0.182 | Electrolyte absorption antagonist | 0.155 0.018 DBMET01480 0.155 0.018 DB12529 0.182 0.011 DB13526 | DB13526 | |
| 0.087 | 0.052 | 0.087 | Inducible nitric-oxide synthase inhibitor | 0.078 0.066 DBMET01480 0.078 0.066 DB12529 0.077 0.068 DB13526 | ||
| 0.077 | 0.046 | 0.108 | Vanilloid 4 agonist | 0.108 0.011 DBMET01480 0.108 0.011 DB12529 0.101 0.016 DB13526 | DB12529 | |
| 0.046 | 0.015 | 0.076 | Glutamate (mGluR8) agonist | 0.076 0.004 DBMET01480 0.076 0.004 DB12529 0.073 0.004 DB13526 | DB12529 | |
| 0.051 | 0.02 | 0.076 | Guanylate cyclase inhibitor | 0.066 0.007 DBMET01480 0.066 0.007 DB12529 0.076 0.004 DB13526 | DB13526 | |
| 0.095 | 0.065 | 0.172 | Sphingomyelinase inhibitor | 0.117 0.044 DBMET01480 0.117 0.044 DB12529 0.172 0.017 DB13526 | DB13526 | |
| 0.088 | 0.058 | 0.134 | Ornithine decarboxylase inhibitor | 0.095 0.05 DBMET01480 0.095 0.05 DB12529 0.134 0.017 DB13526 | DB13526 | |
| 0.083 | 0.054 | 0.102 | Adrenaline agonist | 0.102 0.036 DB13526 | DB13526 | |
| 0.057 | 0.028 | 0.057 | H+/K+-transporting ATPase inhibitor | |||
| 0.094 | 0.065 | 0.142 | Lanosterol 14 alpha demethylase inhibitor | 0.133 0.019 DBMET01480 0.133 0.019 DB12529 0.142 0.015 DB13526 | DB13526 | |
| 0.046 | 0.019 | 0.09 | GABA uptake inhibitor | 0.053 0.014 DBMET01480 0.053 0.014 DB12529 0.09 0.004 DB13526 | DB13526 | |
| 0.077 | 0.049 | 0.12 | GABA B receptor agonist | 0.102 0.015 DBMET01480 0.102 0.015 DB12529 0.12 0.007 DB13526 | DB13526 | |
| 0.06 | 0.033 | 0.06 | Thromboxane antagonist | 0.051 0.041 DB13526 | ||
| 0.036 | 0.009 | 0.041 | Sodium/glucose cotransporter 2 inhibitor | 0.025 0.02 DBMET01480 0.025 0.02 DB12529 0.041 0.008 DB13526 | DB13526 | |
| 0.076 | 0.05 | 0.236 | Catalase inhibitor | 0.152 0.026 DBMET01480 0.152 0.026 DB12529 0.236 0.01 DB13526 | DB13526 | |
| 0.197 | 0.171 | 0.326 | Transcription factor NF kappa B inhibitor | 0.326 0.084 DB13526 | DB13526 | |
| 0.069 | 0.045 | 0.108 | Exportin-1 inhibitor | 0.108 0.006 DBMET01480 0.108 0.006 DB12529 0.09 0.015 DB13526 | DB12529 | |
| 0.105 | 0.08 | 0.191 | Photosensitizer | 0.148 0.032 DBMET01480 0.148 0.032 DB12529 0.191 0.015 DB13526 | DB13526 | |
| 0.059 | 0.035 | 0.059 | Maillard reaction inhibitor | |||
| 0.045 | 0.021 | 0.075 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.075 0.004 DBMET01480 0.075 0.004 DB12529 0.07 0.005 DB13526 | DB12529 | |
| 0.068 | 0.045 | 0.087 | Carbonic anhydrase V inhibitor | 0.073 0.04 DBMET01480 0.073 0.04 DB12529 0.087 0.032 DB13526 | DB13526 | |
| 0.116 | 0.093 | 0.116 | Cytokine production inhibitor | |||
| 0.069 | 0.047 | 0.281 | Phenylalanine 4-hydroxylase inhibitor | 0.132 0.015 DBMET01480 0.132 0.015 DB12529 0.281 0.004 DB13526 | DB13526 | |
| 0.04 | 0.019 | 0.093 | Fumarate hydratase inhibitor | 0.091 0.006 DBMET01480 0.091 0.006 DB12529 0.093 0.006 DB13526 | DB13526 | |
| 0.11 | 0.089 | 0.175 | Cathepsin H inhibitor | 0.175 0.032 DBMET01480 0.175 0.032 DB12529 0.158 0.041 DB13526 | DB12529 | |
| 0.107 | 0.087 | 0.265 | Aldehyde dehydrogenase inhibitor | 0.162 0.041 DBMET01480 0.162 0.041 DB12529 0.265 0.016 DB13526 | DB13526 | |
| 0.038 | 0.018 | 0.038 | Angiotensin II receptor antagonist | |||
| 0.034 | 0.015 | 0.063 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.054 0.008 DBMET01480 0.054 0.008 DB12529 0.063 0.007 DB13526 | DB13526 | |
| 0.029 | 0.012 | 0.034 | Sodium/glucose cotransporter inhibitor | 0.034 0.009 DB13526 | DB13526 | |
| 0.11 | 0.094 | 0.167 | Sphingosine 1-phosphate receptor 4 antagonist | 0.144 0.039 DBMET01480 0.144 0.039 DB12529 0.167 0.021 DB13526 | DB13526 | |
| 0.031 | 0.015 | 0.044 | Purinergic P2Y15 antagonist | 0.044 0.005 DBMET01480 0.044 0.005 DB12529 0.041 0.006 DB13526 | DB12529 | |
| 0.059 | 0.044 | 0.122 | Purinergic P2X1 antagonist | 0.119 0.012 DBMET01480 0.119 0.012 DB12529 0.122 0.011 DB13526 | DB13526 | |
| 0.024 | 0.011 | 0.58 | Corticosteroid-like | 0.58 0 DB12529 0.021 0.015 DB13526 | DB12529 | |
| 0.061 | 0.05 | 0.127 | Interferon inducer | 0.074 0.03 DBMET01480 0.074 0.03 DB12529 0.127 0.006 DB13526 | DB13526 | |
| 0.029 | 0.018 | 0.053 | Estrogen-related receptor gamma antagonist | 0.036 0.007 DBMET01480 0.036 0.007 DB12529 0.053 0.003 DB13526 | DB13526 | |
| 0.064 | 0.054 | 0.102 | Glutamate (mGluR7) antagonist | 0.102 0.01 DBMET01480 0.102 0.01 DB12529 0.089 0.018 DB13526 | DB12529 | |
| 0.019 | 0.01 | 0.026 | Methylmalonyl-CoA mutase inhibitor | 0.022 0.006 DBMET01480 0.022 0.006 DB12529 0.026 0.004 DB13526 | DB13526 | |
| 0.032 | 0.023 | 0.053 | Glutamate (mGluR3) agonist | 0.039 0.01 DBMET01480 0.039 0.01 DB12529 0.053 0.004 DB13526 | DB13526 | |
| 0.085 | 0.076 | 0.139 | Glutamate release inhibitor | 0.125 0.019 DBMET01480 0.125 0.019 DB12529 0.139 0.013 DB13526 | DB13526 | |
| 0.041 | 0.032 | 0.042 | Angiotensin AT1 receptor antagonist | 0.039 0.035 DBMET01480 0.039 0.035 DB12529 0.042 0.029 DB13526 | DB13526 | |
| 0.136 | 0.128 | 0.229 | 3C-like protease (Human coronavirus) inhibitor | 0.229 0.037 DBMET01480 0.229 0.037 DB12529 0.182 0.063 DB13526 | DB12529 | |
| 0.068 | 0.06 | 0.068 | Metalloproteinase-9 inhibitor | |||
| 0.018 | 0.011 | 0.029 | Telomerase stimulant | 0.024 0.004 DBMET01480 0.024 0.004 DB12529 0.029 0.003 DB13526 | DB13526 | |
| 0.025 | 0.018 | 0.054 | Lysophosphatidic acid receptor 1 agonist | 0.032 0.01 DBMET01480 0.032 0.01 DB12529 0.054 0.004 DB13526 | DB13526 | |
| 0.121 | 0.115 | 0.154 | Phospholipase A2 inhibitor | 0.154 0.07 DB13526 | DB13526 | |
| 0.162 | 0.156 | 0.339 | Interleukin agonist | 0.281 0.058 DBMET01480 0.281 0.058 DB12529 0.339 0.032 DB13526 | DB13526 | |
| 0.017 | 0.011 | 0.033 | Carbonic anhydrase X inhibitor | 0.032 0.004 DBMET01480 0.032 0.004 DB12529 0.033 0.004 DB13526 | DB13526 | |
| 0.017 | 0.011 | 0.033 | Carbonic anhydrase VIII inhibitor | 0.032 0.004 DBMET01480 0.032 0.004 DB12529 0.033 0.004 DB13526 | DB13526 | |
| 0.147 | 0.142 | 0.272 | Neurotrophic factor enhancer | 0.213 0.065 DBMET01480 0.213 0.065 DB12529 0.272 0.027 DB13526 | DB13526 | |
| 0.089 | 0.084 | 0.187 | Carbonic anhydrase XV inhibitor | 0.13 0.04 DBMET01480 0.13 0.04 DB12529 0.187 0.021 DB13526 | DB13526 | |
| 0.014 | 0.009 | 0.044 | Lysophosphatidic acid receptor 3 agonist | 0.02 0.005 DBMET01480 0.02 0.005 DB12529 0.044 0.003 DB13526 | DB13526 | |
| 0.138 | 0.134 | 0.186 | Neurotensin receptor agonist | 0.183 0.047 DBMET01480 0.183 0.047 DB12529 0.186 0.044 DB13526 | DB13526 | |
| 0.059 | 0.054 | 0.09 | Protease 3C (Human rhinovirus) inhibitor | 0.077 0.029 DBMET01480 0.077 0.029 DB12529 0.09 0.021 DB13526 | DB13526 | |
| 0.181 | 0.177 | 0.304 | Gastrin inhibitor | 0.267 0.06 DBMET01480 0.267 0.06 DB12529 0.304 0.03 DB13526 | DB13526 | |
| 0.041 | 0.036 | 0.066 | Glutamate (mGluR4) antagonist | 0.058 0.015 DBMET01480 0.058 0.015 DB12529 0.066 0.012 DB13526 | DB13526 | |
| 0.02 | 0.016 | 0.03 | Retinoid X beta receptor antagonist | 0.022 0.011 DBMET01480 0.022 0.011 DB12529 0.03 0.004 DB13526 | DB13526 | |
| 0.071 | 0.068 | 0.165 | Interferon agonist | 0.088 0.041 DBMET01480 0.088 0.041 DB12529 0.165 0.009 DB13526 | DB13526 | |
| 0.06 | 0.057 | 0.081 | Calcium channel P-type blocker | 0.075 0.02 DBMET01480 0.075 0.02 DB12529 0.081 0.014 DB13526 | DB13526 | |
| 0.055 | 0.052 | 0.076 | Potassium channel intermediate-conductance Ca-activated blocker | 0.076 0.02 DBMET01480 0.076 0.02 DB12529 0.069 0.028 DB13526 | DB12529 | |
| 0.015 | 0.012 | 0.021 | Purinergic P2Y1 agonist | 0.02 0.007 DBMET01480 0.02 0.007 DB12529 0.021 0.006 DB13526 | DB13526 | |
| 0.036 | 0.033 | 0.056 | Dihydropteroate synthase inhibitor | 0.056 0.013 DBMET01480 0.056 0.013 DB12529 0.049 0.017 DB13526 | DB12529 | |
| 0.025 | 0.023 | 0.07 | Uridine phosphorylase inhibitor | 0.047 0.009 DBMET01480 0.047 0.009 DB12529 0.07 0.004 DB13526 | DB13526 | |
| 0.011 | 0.01 | 0.02 | Glutamate (mGluR6) agonist | 0.02 0.004 DBMET01480 0.02 0.004 DB12529 0.02 0.004 DB13526 | DB13526 | |
| 0.047 | 0.045 | 0.047 | Carbonic anhydrase IX inhibitor | |||
| 0.044 | 0.043 | 0.044 | Carbonic anhydrase XII inhibitor | |||
| 0.018 | 0.017 | 0.018 | Caspase 8 inhibitor | 0.018 0.017 DB13526 | ||
| 0.045 | 0.045 | 0.086 | Squalene epoxidase inhibitor | 0.059 0.021 DBMET01480 0.059 0.021 DB12529 0.086 0.008 DB13526 | DB13526 | |
| 0.083 | 0.082 | 0.166 | MAP kinase kinase 1 inhibitor | 0.094 0.064 DBMET01480 0.094 0.064 DB12529 0.166 0.011 DB13526 | DB13526 | |
| 0.049 | 0.049 | 0.107 | Sphingosine kinase 2 inhibitor | 0.063 0.028 DBMET01480 0.063 0.028 DB12529 0.107 0.006 DB13526 | DB13526 | |
| 0.097 | 0.097 | 0.125 | Caspase 3 inhibitor | 0.102 0.089 DBMET01480 0.102 0.089 DB12529 0.125 0.054 DB13526 | DB13526 | |
| 0.048 | 0.048 | 0.069 | Nicotinic alpha3beta2 receptor antagonist | 0.065 0.021 DBMET01480 0.065 0.021 DB12529 0.069 0.018 DB13526 | DB13526 | |
| 0.052 | 0.052 | 0.07 | Immunoglobulin Fc receptor antagonist | 0.066 0.015 DBMET01480 0.066 0.015 DB12529 0.07 0.011 DB13526 | DB13526 | |
| 0.057 | 0.058 | 0.139 | Sphingosine 1-phosphate receptor 4 agonist | 0.099 0.026 DBMET01480 0.099 0.026 DB12529 0.139 0.011 DB13526 | DB13526 | |
| 0.02 | 0.021 | 0.065 | Prostaglandin F2 alpha agonist | 0.024 0.014 DBMET01480 0.024 0.014 DB12529 0.065 0.003 DB13526 | DB13526 | |
| 0.025 | 0.027 | 0.039 | Hedgehog signaling activator | 0.034 0.008 DBMET01480 0.034 0.008 DB12529 0.039 0.005 DB13526 | DB13526 | |
| 0.076 | 0.079 | 0.103 | CC chemokine 5 receptor agonist | 0.103 0.019 DBMET01480 0.103 0.019 DB12529 0.086 0.045 DB13526 | DB12529 | |
| 0.013 | 0.016 | 0.027 | Thromboxane A2 agonist | 0.022 0.005 DBMET01480 0.022 0.005 DB12529 0.027 0.004 DB13526 | DB13526 | |
| 0.022 | 0.025 | 0.035 | Glutamate (mGluR1) agonist | 0.03 0.009 DBMET01480 0.03 0.009 DB12529 0.035 0.007 DB13526 | DB13526 | |
| 0.076 | 0.08 | 0.116 | D-Ala-D-Ala ligase inhibitor | 0.116 0.015 DBMET01480 0.116 0.015 DB12529 0.104 0.025 DB13526 | DB12529 | |
| 0.008 | 0.013 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.009 DBMET01480 0.01 0.009 DB12529 0.01 0.008 DB13526 | DB13526 | |
| 0.04 | 0.045 | 0.048 | Thromboxane A2 antagonist | 0.048 0.038 DB13526 | DB13526 | |
| 0.063 | 0.069 | 0.215 | Topoisomerase II alpha inhibitor | 0.215 0.013 DB13526 | DB13526 | |
| 0.04 | 0.045 | 0.051 | Heme oxygenase inhibitor | 0.051 0.012 DBMET01480 0.051 0.012 DB12529 0.049 0.015 DB13526 | DB12529 | |
| 0.029 | 0.035 | 0.049 | Retinoid X alpha receptor antagonist | 0.035 0.023 DBMET01480 0.035 0.023 DB12529 0.049 0.007 DB13526 | DB13526 | |
| 0.033 | 0.039 | 0.068 | Membrane dipeptidase inhibitor | 0.049 0.016 DBMET01480 0.049 0.016 DB12529 0.068 0.008 DB13526 | DB13526 | |
| 0.022 | 0.028 | 0.035 | Vanilloid 2 agonist | 0.035 0.005 DBMET01480 0.035 0.005 DB12529 0.033 0.007 DB13526 | DB12529 | |
| 0.095 | 0.101 | 0.209 | Microtubule formation inhibitor | 0.136 0.046 DBMET01480 0.136 0.046 DB12529 0.209 0.018 DB13526 | DB13526 | |
| 0.032 | 0.039 | 0.056 | Retinoid X receptor antagonist | 0.039 0.025 DBMET01480 0.039 0.025 DB12529 0.056 0.008 DB13526 | DB13526 | |
| 0.043 | 0.051 | 0.061 | Cytokine production stimulant | 0.053 0.022 DBMET01480 0.053 0.022 DB12529 0.061 0.012 DB13526 | DB13526 | |
| 0.033 | 0.041 | 0.076 | Dopamine D5 agonist | 0.076 0.007 DBMET01480 0.076 0.007 DB12529 0.063 0.011 DB13526 | DB12529 | |
| 0.12 | 0.129 | 0.16 | Pregnane X receptor agonist | 0.152 0.05 DBMET01480 0.152 0.05 DB12529 0.16 0.037 DB13526 | DB13526 | |
| 0.002 | 0.011 | 0.007 | Transcortin receptor antagonist | 0.007 0.003 DB13526 | DB13526 | |
| 0.054 | 0.064 | 0.096 | Acetylcholine M5 receptor agonist | 0.096 0.023 DBMET01480 0.096 0.023 DB12529 0.085 0.03 DB13526 | DB12529 | |
| 0.038 | 0.049 | 0.056 | Glutamate (mGluR group III) antagonist | 0.052 0.019 DBMET01480 0.052 0.019 DB12529 0.056 0.016 DB13526 | DB13526 | |
| 0.002 | 0.013 | 0.004 | Reverse transcriptase (HBV) inhibitor | 0.004 0.003 DB13526 | DB13526 | |
| 0.082 | 0.094 | 0.114 | Bile acid receptor antagonist | 0.097 0.057 DBMET01480 0.097 0.057 DB12529 0.114 0.026 DB13526 | DB13526 | |
| 0.08 | 0.092 | 0.158 | Carbonic anhydrase III inhibitor | 0.136 0.034 DBMET01480 0.136 0.034 DB12529 0.158 0.026 DB13526 | DB13526 | |
| 0.037 | 0.049 | 0.093 | Adenylate cyclase 1 inhibitor | 0.077 0.009 DBMET01480 0.077 0.009 DB12529 0.093 0.005 DB13526 | DB13526 | |
| 0.046 | 0.059 | 0.123 | Glucosylceramidase inhibitor | 0.055 0.038 DBMET01480 0.055 0.038 DB12529 0.123 0.005 DB13526 | DB13526 | |
| 0.008 | 0.021 | 0.017 | Carbonic anhydrase XI inhibitor | 0.017 0.005 DBMET01480 0.017 0.005 DB12529 0.013 0.008 DB13526 | DB12529 | |
| 0.124 | 0.136 | 0.189 | Antipruritic | 0.189 0.057 DB13526 | DB13526 | |
| 0.089 | 0.103 | 0.213 | Cholesterol synthesis inhibitor | 0.129 0.057 DBMET01480 0.129 0.057 DB12529 0.213 0.024 DB13526 | DB13526 | |
| 0.03 | 0.044 | 0.039 | Delayed rectifier potassium channel blocker | 0.036 0.029 DBMET01480 0.036 0.029 DB12529 0.039 0.022 DB13526 | DB13526 | |
| 0.021 | 0.034 | 0.036 | Nicotinic alpha4beta2 receptor agonist | 0.036 0.011 DBMET01480 0.036 0.011 DB12529 0.03 0.017 DB13526 | DB12529 | |
| 0.016 | 0.03 | 0.044 | Glutamate (mGluR1a) agonist | 0.036 0.007 DBMET01480 0.036 0.007 DB12529 0.044 0.005 DB13526 | DB13526 | |
| 0.027 | 0.041 | 0.04 | HMG CoA reductase inhibitor | 0.04 0.015 DB13526 | DB13526 | |
| 0.015 | 0.029 | 0.027 | Antibiotic Anthracycline-like | 0.021 0.009 DBMET01480 0.021 0.009 DB12529 0.027 0.004 DB13526 | DB13526 | |
| 0.061 | 0.076 | 0.112 | Phospholipase D inhibitor | 0.097 0.016 DBMET01480 0.097 0.016 DB12529 0.112 0.009 DB13526 | DB13526 | |
| 0.062 | 0.078 | 0.122 | GABA aminotransferase inhibitor | 0.104 0.024 DBMET01480 0.104 0.024 DB12529 0.122 0.015 DB13526 | DB13526 | |
| 0.194 | 0.21 | 0.488 | Histamine release inhibitor | 0.388 0.082 DBMET01480 0.388 0.082 DB12529 0.488 0.033 DB13526 | DB13526 | |
| 0.05 | 0.067 | 0.11 | NMDA receptor agonist | 0.092 0.023 DBMET01480 0.092 0.023 DB12529 0.11 0.016 DB13526 | DB13526 | |
| 0.074 | 0.091 | 0.162 | Prolactin inhibitor | 0.148 0.023 DBMET01480 0.148 0.023 DB12529 0.162 0.018 DB13526 | DB13526 | |
| 0.017 | 0.034 | 0.03 | Isoleucine-tRNA ligase inhibitor | 0.026 0.01 DBMET01480 0.026 0.01 DB12529 0.03 0.005 DB13526 | DB13526 | |
| 0.119 | 0.136 | 0.201 | Melanin inhibitor | 0.159 0.071 DBMET01480 0.159 0.071 DB12529 0.201 0.04 DB13526 | DB13526 | |
| 0.028 | 0.046 | 0.073 | Toll-Like receptor 2 agonist | 0.044 0.026 DBMET01480 0.044 0.026 DB12529 0.073 0.017 DB13526 | DB13526 | |
| 0.022 | 0.041 | 0.037 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.029 0.013 DBMET01480 0.029 0.013 DB12529 0.037 0.006 DB13526 | DB13526 | |
| 0.019 | 0.039 | 0.037 | Nicotinic acid receptor 2 antagonist | 0.034 0.009 DBMET01480 0.034 0.009 DB12529 0.037 0.006 DB13526 | DB13526 | |
| 0.021 | 0.041 | 0.034 | Complement factor 1s inhibitor | 0.034 0.005 DBMET01480 0.034 0.005 DB12529 0.025 0.02 DB13526 | DB12529 | |
| 0.021 | 0.042 | 0.035 | Thymidine phosphorylase inhibitor | 0.031 0.011 DBMET01480 0.031 0.011 DB12529 0.035 0.009 DB13526 | DB13526 | |
| 0.041 | 0.062 | 0.118 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.067 0.024 DBMET01480 0.067 0.024 DB12529 0.118 0.008 DB13526 | DB13526 | |
| 0.027 | 0.048 | 0.053 | Ceramide glucosyltransferase inhibitor | 0.034 0.028 DBMET01480 0.034 0.028 DB12529 0.053 0.005 DB13526 | DB13526 | |
| 0.051 | 0.073 | 0.075 | Ryanodine receptor antagonist | 0.075 0.012 DBMET01480 0.075 0.012 DB12529 0.07 0.017 DB13526 | DB12529 | |
| 0.067 | 0.089 | 0.104 | Glutathione S-transferase inhibitor | 0.095 0.042 DBMET01480 0.095 0.042 DB12529 0.104 0.033 DB13526 | DB13526 | |
| 0.008 | 0.03 | 0.017 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.017 0.005 DBMET01480 0.017 0.005 DB12529 0.014 0.008 DB13526 | DB12529 | |
| 0.044 | 0.066 | 0.106 | NMDA receptor glycine site agonist | 0.097 0.018 DBMET01480 0.097 0.018 DB12529 0.106 0.014 DB13526 | DB13526 | |
| 0.005 | 0.027 | 0.015 | Thromboxane agonist | 0.01 0.009 DBMET01480 0.01 0.009 DB12529 0.015 0.005 DB13526 | DB13526 | |
| 0.045 | 0.068 | 0.078 | Dihydroorotate oxidase inhibitor | 0.077 0.012 DBMET01480 0.077 0.012 DB12529 0.078 0.012 DB13526 | DB13526 | |
| 0.055 | 0.078 | 0.079 | Transcription factor RelA inhibitor | 0.079 0.018 DBMET01480 0.079 0.018 DB12529 0.06 0.054 DB13526 | DB12529 | |
| 0.01 | 0.034 | 0.016 | Nicotinic alpha4 receptor agonist | 0.016 0.012 DBMET01480 0.016 0.012 DB12529 | DB12529 | |
| 0.003 | 0.027 | 0.006 | CC chemokine 6 receptor agonist | 0.006 0.005 DBMET01480 0.006 0.005 DB12529 | DB12529 | |
| 0.031 | 0.055 | 0.068 | Histamine H2 receptor agonist | 0.068 0.011 DBMET01480 0.068 0.011 DB12529 0.042 0.031 DB13526 | DB12529 | |
| 0.032 | 0.057 | 0.072 | Geranyltranstransferase inhibitor | 0.057 0.016 DBMET01480 0.057 0.016 DB12529 0.072 0.007 DB13526 | DB13526 | |
| 0.023 | 0.048 | 0.069 | Retinoid X alpha receptor agonist | 0.035 0.024 DBMET01480 0.035 0.024 DB12529 0.069 0.009 DB13526 | DB13526 | |
| 0.033 | 0.059 | 0.061 | Nerve growth factor antagonist | 0.061 0.009 DBMET01480 0.061 0.009 DB12529 0.05 0.018 DB13526 | DB12529 | |
| 0.015 | 0.042 | 0.023 | Factor XIII inhibitor | 0.023 0.01 DBMET01480 0.023 0.01 DB12529 | DB12529 | |
| 0.024 | 0.051 | 0.031 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.031 0.03 DB13526 | DB13526 | |
| 0.107 | 0.134 | 0.176 | Sphingosine 1-phosphate receptor 2 antagonist | 0.151 0.039 DBMET01480 0.151 0.039 DB12529 0.176 0.017 DB13526 | DB13526 | |
| 0.004 | 0.031 | 0.009 | Progesterone receptor A antagonist | 0.009 0.007 DBMET01480 0.009 0.007 DB12529 | DB12529 | |
| 0.016 | 0.044 | 0.044 | Lysine carboxypeptidase inhibitor | 0.029 0.017 DBMET01480 0.029 0.017 DB12529 0.044 0.009 DB13526 | DB13526 | |
| 0.013 | 0.04 | 0.017 | CXC chemokine 5 receptor antagonist | 0.017 0.015 DBMET01480 0.017 0.015 DB12529 | DB12529 | |
| 0.009 | 0.038 | 0.022 | Cyclin T1 inhibitor | 0.021 0.01 DBMET01480 0.021 0.01 DB12529 0.022 0.009 DB13526 | DB13526 | |
| 0.011 | 0.04 | 0.02 | Vitamin D receptor agonist | 0.02 0.007 DB13526 | DB13526 | |
| 0.022 | 0.051 | 0.069 | Phosphoglycerate kinase inhibitor | 0.043 0.018 DBMET01480 0.043 0.018 DB12529 0.069 0.01 DB13526 | DB13526 | |
| 0.081 | 0.111 | 0.188 | Mucolytic | 0.131 0.045 DBMET01480 0.131 0.045 DB12529 0.188 0.016 DB13526 | DB13526 | |
| 0.03 | 0.06 | 0.064 | Antimetabolite | 0.064 0.024 DB13526 | DB13526 | |
| 0.02 | 0.05 | 0.04 | Calcitonin receptor agonist | 0.03 0.027 DBMET01480 0.03 0.027 DB12529 0.04 0.02 DB13526 | DB13526 | |
| 0.102 | 0.132 | 0.241 | Cell wall synthesis inhibitor | 0.171 0.046 DBMET01480 0.171 0.046 DB12529 0.241 0.018 DB13526 | DB13526 | |
| 0.069 | 0.098 | 0.192 | HIV-1 integrase (Overall Integration) inhibitor | 0.157 0.023 DBMET01480 0.157 0.023 DB12529 0.192 0.013 DB13526 | DB13526 | |
| 0.003 | 0.033 | 0.008 | DNA topoisomerase III inhibitor | 0.008 0.004 DBMET01480 0.008 0.004 DB12529 | DB12529 | |
| 0.054 | 0.084 | 0.075 | Beta 2 adrenoreceptor agonist | 0.075 0.013 DB13526 | DB13526 | |
| 0.012 | 0.043 | 0.027 | Estrogen-related receptor gamma agonist | 0.027 0.005 DB13526 | DB13526 | |
| 0.033 | 0.064 | 0.045 | CF transmembrane conductance regulator antagonist | 0.04 0.026 DBMET01480 0.04 0.026 DB12529 0.045 0.014 DB13526 | DB13526 | |
| 0.036 | 0.067 | 0.057 | Diacylglycerol O-acyltransferase inhibitor | 0.057 0.029 DB13526 | DB13526 | |
| 0.018 | 0.049 | 0.041 | Nicotinic alpha3beta4 receptor agonist | 0.041 0.009 DBMET01480 0.041 0.009 DB12529 | DB12529 | |
| 0.041 | 0.073 | 0.068 | Heparanase inhibitor | 0.051 0.041 DBMET01480 0.051 0.041 DB12529 0.068 0.013 DB13526 | DB13526 | |
| 0.019 | 0.05 | 0.03 | Acid ceramidase inhibitor | 0.03 0.009 DBMET01480 0.03 0.009 DB12529 0.024 0.021 DB13526 | DB12529 | |
| 0.029 | 0.06 | 0.048 | Potassium channel Kv1.1 blocker | 0.048 0.014 DBMET01480 0.048 0.014 DB12529 | DB12529 | |
| 0.067 | 0.098 | 0.106 | MAP kinase kinase 7 inhibitor | 0.091 0.022 DBMET01480 0.091 0.022 DB12529 0.106 0.009 DB13526 | DB13526 | |
| 0.055 | 0.087 | 0.127 | CYP2A6 inhibitor | 0.127 0.024 DBMET01480 0.127 0.024 DB12529 0.074 0.054 DB13526 | DB12529 | |
| 0.026 | 0.058 | 0.054 | Oxytocin agonist | 0.054 0.021 DBMET01480 0.054 0.021 DB12529 0.054 0.021 DB13526 | DB13526 | |
| 0.015 | 0.047 | 0.029 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.023 0.01 DBMET01480 0.023 0.01 DB12529 0.029 0.005 DB13526 | DB13526 | |
| 0.009 | 0.042 | 0.016 | Cyclin D2 inhibitor | 0.013 0.01 DBMET01480 0.013 0.01 DB12529 0.016 0.005 DB13526 | DB13526 | |
| 0.028 | 0.061 | 0.074 | Adenosine deaminase inhibitor | 0.057 0.024 DBMET01480 0.057 0.024 DB12529 0.074 0.011 DB13526 | DB13526 | |
| 0.03 | 0.063 | 0.053 | Vanilloid 3 antagonist | 0.042 0.018 DBMET01480 0.042 0.018 DB12529 0.053 0.007 DB13526 | DB13526 | |
| 0.017 | 0.05 | 0.064 | Arginase inhibitor | 0.044 0.019 DBMET01480 0.044 0.019 DB12529 0.064 0.009 DB13526 | DB13526 | |
| 0.037 | 0.071 | 0.062 | Dopamine beta hydroxylase inhibitor | 0.062 0.013 DBMET01480 0.062 0.013 DB12529 0.06 0.015 DB13526 | DB12529 | |
| 0.037 | 0.071 | 0.052 | HCV NS3/NS4A protease inhibitor | 0.046 0.04 DBMET01480 0.046 0.04 DB12529 0.052 0.029 DB13526 | DB13526 | |
| 0.058 | 0.092 | 0.107 | MDM2 inhibitor | 0.077 0.025 DBMET01480 0.077 0.025 DB12529 0.107 0.005 DB13526 | DB13526 | |
| 0.006 | 0.041 | 0.012 | Purine nucleoside phosphorylase inhibitor | 0.012 0.007 DB13526 | DB13526 | |
| 0.014 | 0.049 | 0.028 | Neuraminidase (Influenza B) inhibitor | 0.023 0.011 DBMET01480 0.023 0.011 DB12529 0.028 0.005 DB13526 | DB13526 | |
| 0.037 | 0.072 | 0.053 | Bombesin 2 receptor antagonist | 0.049 0.034 DBMET01480 0.049 0.034 DB12529 0.053 0.03 DB13526 | DB13526 | |
| 0.024 | 0.059 | 0.039 | Melatonin receptor 1A agonist | 0.033 0.025 DBMET01480 0.033 0.025 DB12529 0.039 0.014 DB13526 | DB13526 | |
| 0.041 | 0.076 | 0.088 | Androgen agonist | 0.07 0.031 DBMET01480 0.07 0.031 DB12529 0.088 0.02 DB13526 | DB13526 | |
| 0.011 | 0.047 | 0.016 | CC chemokine 9 receptor antagonist | 0.016 0.013 DBMET01480 0.016 0.013 DB12529 | DB12529 | |
| 0.047 | 0.084 | 0.067 | Leukotriene C antagonist | 0.055 0.045 DBMET01480 0.055 0.045 DB12529 0.067 0.017 DB13526 | DB13526 | |
| 0.081 | 0.119 | 0.296 | Amylase inhibitor | 0.189 0.048 DBMET01480 0.189 0.048 DB12529 0.296 0.019 DB13526 | DB13526 | |
| 0.044 | 0.082 | 0.094 | Sphingosine kinase inhibitor | 0.055 0.049 DBMET01480 0.055 0.049 DB12529 0.094 0.009 DB13526 | DB13526 | |
| 0.029 | 0.069 | 0.064 | Thymidine kinase inhibitor | 0.045 0.023 DBMET01480 0.045 0.023 DB12529 0.064 0.012 DB13526 | DB13526 | |
| 0.017 | 0.057 | 0.067 | Retinoid X receptor agonist | 0.03 0.029 DBMET01480 0.03 0.029 DB12529 0.067 0.011 DB13526 | DB13526 | |
| 0.038 | 0.078 | 0.056 | Leukotriene B4 antagonist | 0.056 0.033 DB13526 | DB13526 | |
| 0.009 | 0.05 | 0.019 | Nicotinic acid receptor 1 antagonist | 0.019 0.01 DBMET01480 0.019 0.01 DB12529 0.018 0.011 DB13526 | DB12529 | |
| 0.009 | 0.052 | 0.029 | Prostaglandin H2 antagonist | 0.029 0.014 DB13526 | DB13526 | |
| 0.029 | 0.071 | 0.064 | Sphingosine kinase 1 inhibitor | 0.064 0.008 DB13526 | DB13526 | |
| 0.014 | 0.057 | 0.031 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.026 0.012 DBMET01480 0.026 0.012 DB12529 0.031 0.007 DB13526 | DB13526 | |
| 0.058 | 0.101 | 0.133 | Carbonic anhydrase VI inhibitor | 0.096 0.042 DBMET01480 0.096 0.042 DB12529 0.133 0.025 DB13526 | DB13526 | |
| 0.032 | 0.075 | 0.056 | Histamine H1 receptor agonist | 0.056 0.012 DBMET01480 0.056 0.012 DB12529 | DB12529 | |
| 0.011 | 0.054 | 0.026 | 5-Alpha-reductase 2 inhibitor | 0.026 0.01 DB13526 | DB13526 | |
| 0.013 | 0.059 | 0.024 | Protease (Human cytomegalovirus) inhibitor | 0.024 0.012 DBMET01480 0.024 0.012 DB12529 | DB12529 | |
| 0.022 | 0.068 | 0.07 | Alpha 1d adrenoreceptor agonist | 0.07 0.007 DBMET01480 0.07 0.007 DB12529 0.047 0.019 DB13526 | DB12529 | |
| 0.057 | 0.104 | 0.122 | Histamine N-methyltransferase inhibitor | 0.122 0.028 DBMET01480 0.122 0.028 DB12529 0.107 0.04 DB13526 | DB12529 | |
| 0.03 | 0.077 | 0.045 | Leukotriene C4 antagonist | 0.045 0.015 DB13526 | DB13526 | |
| 0.029 | 0.077 | 0.057 | AICAR transformylase inhibitor | 0.057 0.016 DBMET01480 0.057 0.016 DB12529 0.049 0.024 DB13526 | DB12529 | |
| 0.067 | 0.115 | 0.108 | mTOR complex 2 inhibitor | 0.102 0.031 DBMET01480 0.102 0.031 DB12529 0.108 0.025 DB13526 | DB13526 | |
| 0.017 | 0.065 | 0.027 | 5 Hydroxytryptamine 4 agonist | 0.027 0.011 DB13526 | DB13526 | |
| 0.026 | 0.075 | 0.043 | AMPA 4 receptor antagonist | 0.042 0.023 DBMET01480 0.042 0.023 DB12529 0.043 0.022 DB13526 | DB13526 | |
| 0.092 | 0.141 | 0.232 | Protein kinase stimulant | 0.142 0.074 DBMET01480 0.142 0.074 DB12529 0.232 0.031 DB13526 | DB13526 | |
| 0.018 | 0.068 | 0.044 | Lysophosphatidic acid 2 receptor antagonist | 0.028 0.024 DBMET01480 0.028 0.024 DB12529 0.044 0.01 DB13526 | DB13526 | |
| 0.02 | 0.07 | 0.028 | Glucosylceramidase stimulant | 0.028 0.018 DBMET01480 0.028 0.018 DB12529 | DB12529 | |
| 0.037 | 0.088 | 0.051 | CD45 antagonist | 0.048 0.04 DBMET01480 0.048 0.04 DB12529 0.051 0.033 DB13526 | DB13526 | |
| 0.018 | 0.069 | 0.034 | Epoxide hydrolase 1 inhibitor | 0.034 0.016 DBMET01480 0.034 0.016 DB12529 | DB12529 | |
| 0.023 | 0.074 | 0.044 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.044 0.016 DB13526 | DB13526 | |
| 0.166 | 0.218 | 0.283 | Insulysin inhibitor | 0.279 0.073 DBMET01480 0.279 0.073 DB12529 0.283 0.069 DB13526 | DB13526 | |
| 0.016 | 0.068 | 0.03 | Peptide deformylase inhibitor | 0.03 0.021 DB13526 | DB13526 | |
| 0.054 | 0.106 | 0.096 | Androgen antagonist | 0.096 0.05 DB13526 | DB13526 | |
| 0.047 | 0.1 | 0.063 | Potassium channel (ATP-sensitive) blocker | 0.063 0.053 DB13526 | DB13526 | |
| 0.022 | 0.075 | 0.033 | Carboxypeptidase B inhibitor | 0.033 0.022 DB13526 | DB13526 | |
| 0.012 | 0.066 | 0.021 | Lysophosphatidic acid 1 receptor antagonist | 0.021 0.016 DB13526 | DB13526 | |
| 0.032 | 0.086 | 0.065 | Aldosterone antagonist | 0.052 0.027 DBMET01480 0.052 0.027 DB12529 0.065 0.016 DB13526 | DB13526 | |
| 0.022 | 0.077 | 0.055 | Glutamate (mGluR3) antagonist | 0.041 0.02 DBMET01480 0.041 0.02 DB12529 0.055 0.01 DB13526 | DB13526 | |
| 0.007 | 0.061 | 0.021 | 5-Alpha-reductase 1 inhibitor | 0.021 0.01 DB13526 | DB13526 | |
| 0.003 | 0.058 | 0.006 | Integrin alpha5beta6 antagonist | 0.006 0.005 DBMET01480 0.006 0.005 DB12529 | DB12529 | |
| 0.074 | 0.13 | 0.138 | Proteasome inhibitor | 0.095 0.094 DBMET01480 0.095 0.094 DB12529 0.138 0.053 DB13526 | DB13526 | |
| 0.026 | 0.082 | 0.071 | Fructose-1,6-bisphosphatase inhibitor | 0.053 0.022 DBMET01480 0.053 0.022 DB12529 0.071 0.012 DB13526 | DB13526 | |
| 0.004 | 0.061 | 0.018 | G-protein-coupled receptor 120 agonist | 0.018 0.011 DB13526 | DB13526 | |
| 0.095 | 0.152 | 0.141 | DNA repair enzyme inhibitor | 0.13 0.055 DBMET01480 0.13 0.055 DB12529 0.141 0.041 DB13526 | DB13526 | |
| 0.036 | 0.096 | 0.072 | Sphingosine 1-phosphate receptor 3 antagonist | 0.055 0.046 DBMET01480 0.055 0.046 DB12529 0.072 0.024 DB13526 | DB13526 | |
| 0.016 | 0.075 | 0.028 | Integrin alpha2beta1 antagonist | 0.028 0.015 DBMET01480 0.028 0.015 DB12529 0.028 0.015 DB13526 | DB13526 | |
| 0.083 | 0.142 | 0.197 | Toll-Like receptor 2 antagonist | 0.137 0.062 DBMET01480 0.137 0.062 DB12529 0.197 0.025 DB13526 | DB13526 | |
| 0.035 | 0.096 | 0.049 | Beta adrenoreceptor agonist | 0.049 0.02 DB13526 | DB13526 | |
| 0.005 | 0.067 | 0.022 | Ileal bile acid transport inhibitor | 0.022 0.008 DB13526 | DB13526 | |
| 0.029 | 0.091 | 0.046 | GABA B receptor antagonist | 0.044 0.028 DBMET01480 0.044 0.028 DB12529 0.046 0.024 DB13526 | DB13526 | |
| 0.075 | 0.137 | 0.119 | Glutamate (mGluR7) agonist | 0.119 0.031 DBMET01480 0.119 0.031 DB12529 0.112 0.039 DB13526 | DB12529 | |
| 0.12 | 0.185 | 0.164 | Heat shock protein 70 antagonist | 0.153 0.04 DBMET01480 0.153 0.04 DB12529 0.164 0.023 DB13526 | DB13526 | |
| 0.014 | 0.079 | 0.037 | Potassium channel small-conductance Ca-activated activator | 0.037 0.017 DBMET01480 0.037 0.017 DB12529 | DB12529 | |
| 0.014 | 0.079 | 0.057 | 5-Alpha-reductase inhibitor | 0.057 0.017 DB13526 | DB13526 | |
| 0.015 | 0.081 | 0.043 | Free fatty acid receptor 1 antagonist | 0.034 0.023 DBMET01480 0.034 0.023 DB12529 0.043 0.013 DB13526 | DB13526 | |
| 0.041 | 0.107 | 0.116 | Carbonic anhydrase XIII inhibitor | 0.086 0.046 DBMET01480 0.086 0.046 DB12529 0.116 0.031 DB13526 | DB13526 | |
| 0.013 | 0.079 | 0.064 | Prostaglandin agonist | 0.064 0.008 DB13526 | DB13526 | |
| 0.01 | 0.076 | 0.022 | Imidazoline I1 receptor antagonist | 0.022 0.012 DBMET01480 0.022 0.012 DB12529 | DB12529 | |
| 0.044 | 0.111 | 0.108 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.091 0.043 DBMET01480 0.091 0.043 DB12529 0.108 0.034 DB13526 | DB13526 | |
| 0.017 | 0.085 | 0.031 | MAP3K8 inhibitor | 0.031 0.016 DBMET01480 0.031 0.016 DB12529 | DB12529 | |
| 0.01 | 0.079 | 0.026 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.026 0.021 DB13526 | DB13526 | |
| 0.029 | 0.099 | 0.043 | Cholesterol esterase inhibitor | 0.043 0.042 DB13526 | DB13526 | |
| 0.016 | 0.087 | 0.034 | ATP citrate lysase inhibitor | 0.029 0.027 DBMET01480 0.029 0.027 DB12529 0.034 0.018 DB13526 | DB13526 | |
| 0.007 | 0.077 | 0.015 | Adenosine A2 receptor agonist | 0.015 0.012 DB13526 | DB13526 | |
| 0.002 | 0.072 | 0.028 | Mannitol 2-dehydrogenase inhibitor | 0.028 0.002 DB13526 | DB13526 | |
| 0.007 | 0.078 | 0.037 | Prostaglandin EP2 agonist | 0.037 0.01 DB13526 | DB13526 | |
| 0.013 | 0.084 | 0.02 | Toll-Like receptor 8 agonist | 0.02 0.014 DB13526 | DB13526 | |
| 0.018 | 0.089 | 0.061 | Vascular adhesion protein 1 inhibitor | 0.036 0.031 DBMET01480 0.036 0.031 DB12529 0.061 0.009 DB13526 | DB13526 | |
| 0.022 | 0.094 | 0.04 | Integrin alpha2 antagonist | 0.04 0.021 DBMET01480 0.04 0.021 DB12529 0.038 0.023 DB13526 | DB12529 | |
| 0.02 | 0.093 | 0.062 | Ribonucleotide reductase inhibitor | 0.062 0.035 DB13526 | DB13526 | |
| 0.025 | 0.098 | 0.038 | Adenosine uptake inhibitor | 0.038 0.016 DBMET01480 0.038 0.016 DB12529 0.033 0.029 DB13526 | DB12529 | |
| 0.021 | 0.095 | 0.033 | Glutamate (mGluR4) agonist | 0.033 0.025 DBMET01480 0.033 0.025 DB12529 | DB12529 | |
| 0.034 | 0.108 | 0.067 | Carbonic anhydrase stimulant | 0.066 0.035 DBMET01480 0.066 0.035 DB12529 0.067 0.034 DB13526 | DB13526 | |
| 0.065 | 0.14 | 0.186 | 5 Hydroxytryptamine 3A agonist | 0.186 0.019 DBMET01480 0.186 0.019 DB12529 0.11 0.065 DB13526 | DB12529 | |
| 0.02 | 0.096 | 0.06 | Ribonucleoside-diphosphate reductase inhibitor | 0.06 0.034 DB13526 | DB13526 | |
| 0.037 | 0.113 | 0.087 | Carbonic anhydrase VA inhibitor | 0.077 0.039 DBMET01480 0.077 0.039 DB12529 0.087 0.032 DB13526 | DB13526 | |
| 0.05 | 0.125 | 0.079 | Potassium channel (Tandem pore domain) blocker | 0.079 0.036 DBMET01480 0.079 0.036 DB12529 0.077 0.043 DB13526 | DB12529 | |
| 0.045 | 0.122 | 0.076 | Beta 3 adrenoreceptor antagonist | 0.076 0.027 DB13526 | DB13526 | |
| 0.035 | 0.112 | 0.055 | Thromboxane synthase inhibitor | 0.055 0.036 DB13526 | DB13526 | |
| 0.006 | 0.085 | 0.018 | Alpha 2a adrenoreceptor agonist | 0.018 0.011 DBMET01480 0.018 0.011 DB12529 | DB12529 | |
| 0.038 | 0.118 | 0.073 | 5 Hydroxytryptamine 3 agonist | 0.072 0.034 DBMET01480 0.072 0.034 DB12529 0.073 0.033 DB13526 | DB13526 | |
| 0.015 | 0.094 | 0.054 | Farnesoid X receptor agonist | 0.054 0.013 DB13526 | DB13526 | |
| 0.085 | 0.165 | 0.151 | Transcription factor STAT6 inhibitor | 0.122 0.057 DBMET01480 0.122 0.057 DB12529 0.151 0.022 DB13526 | DB13526 | |
| 0.021 | 0.101 | 0.051 | Glutamate (mGluR1a) antagonist | 0.051 0.02 DB13526 | DB13526 | |
| 0.012 | 0.093 | 0.039 | Kainate receptor 2 antagonist | 0.039 0.023 DBMET01480 0.039 0.023 DB12529 0.031 0.029 DB13526 | DB12529 | |
| 0.014 | 0.095 | 0.025 | Thyroid hormone agonist | 0.025 0.019 DB13526 | DB13526 | |
| 0.041 | 0.123 | 0.088 | Nicotinic alpha4beta2 receptor antagonist | 0.088 0.042 DBMET01480 0.088 0.042 DB12529 0.076 0.054 DB13526 | DB12529 | |
| 0.022 | 0.104 | 0.043 | Tryptophan 5 hydroxylase inhibitor | 0.038 0.02 DBMET01480 0.038 0.02 DB12529 0.043 0.01 DB13526 | DB13526 | |
| 0.028 | 0.11 | 0.065 | Histamine agonist | 0.065 0.023 DB13526 | DB13526 | |
| 0.058 | 0.141 | 0.174 | Expectorant | 0.102 0.066 DBMET01480 0.102 0.066 DB12529 0.174 0.027 DB13526 | DB13526 | |
| 0.148 | 0.233 | 0.222 | Neuropeptide Y2 antagonist | 0.2 0.119 DBMET01480 0.2 0.119 DB12529 0.222 0.086 DB13526 | DB13526 | |
| 0.054 | 0.14 | 0.084 | Estrogen receptor alpha antagonist | 0.084 0.043 DB13526 | DB13526 | |
| 0.011 | 0.098 | 0.032 | Liver X receptor beta antagonist | 0.032 0.017 DB13526 | DB13526 | |
| 0.027 | 0.115 | 0.047 | Prolyl endopeptidase inhibitor | 0.047 0.04 DBMET01480 0.047 0.04 DB12529 0.046 0.042 DB13526 | DB12529 | |
| 0.015 | 0.104 | 0.031 | Carnitine palmitoyltransferase 1 inhibitor | 0.031 0.029 DB13526 | DB13526 | |
| 0.025 | 0.115 | 0.056 | Beta 2 adrenoreceptor antagonist | 0.056 0.028 DB13526 | DB13526 | |
| 0.053 | 0.143 | 0.145 | Alcohol dehydrogenase inhibitor | 0.11 0.042 DBMET01480 0.11 0.042 DB12529 0.145 0.022 DB13526 | DB13526 | |
| 0.026 | 0.117 | 0.048 | Potassium channel (Inward rectifier) blocker | 0.048 0.036 DB13526 | DB13526 | |
| 0.028 | 0.12 | 0.056 | Acetylcholine M5 receptor antagonist | 0.056 0.048 DB13526 | DB13526 | |
| 0.023 | 0.115 | 0.037 | 5 Hydroxytryptamine 2B agonist | 0.037 0.032 DBMET01480 0.037 0.032 DB12529 | DB12529 | |
| 0.007 | 0.099 | 0.117 | Squalene synthetase inhibitor | 0.117 0.005 DB13526 | DB13526 | |
| 0.014 | 0.107 | 0.031 | Carnitine palmitoyltransferase inhibitor | 0.031 0.029 DB13526 | DB13526 | |
| 0.031 | 0.124 | 0.059 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.057 0.042 DBMET01480 0.057 0.042 DB12529 0.059 0.04 DB13526 | DB13526 | |
| 0.015 | 0.108 | 0.028 | 5 Hydroxytryptamine 6 agonist | 0.028 0.022 DBMET01480 0.028 0.022 DB12529 | DB12529 | |
| 0.045 | 0.139 | 0.093 | Macrophage migration inhibitory factor inhibitor | 0.093 0.039 DB13526 | DB13526 | |
| 0.012 | 0.107 | 0.042 | Nicotinic acid receptor agonist | 0.042 0.019 DB13526 | DB13526 | |
| 0.054 | 0.149 | 0.131 | Falcipain 3 inhibitor | 0.126 0.05 DBMET01480 0.126 0.05 DB12529 0.131 0.046 DB13526 | DB13526 | |
| 0.045 | 0.14 | 0.062 | Histone deacetylase SIRT3 inhibitor | 0.062 0.044 DBMET01480 0.062 0.044 DB12529 | DB12529 | |
| 0.072 | 0.168 | 0.13 | TRPA1 agonist | 0.13 0.048 DBMET01480 0.13 0.048 DB12529 0.125 0.053 DB13526 | DB12529 | |
| 0.012 | 0.108 | 0.032 | Methionyl aminopeptidase 1 inhibitor | 0.032 0.023 DBMET01480 0.032 0.023 DB12529 0.032 0.022 DB13526 | DB13526 | |
| 0.012 | 0.109 | 0.03 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.03 0.024 DB13526 | DB13526 | |
| 0.022 | 0.119 | 0.049 | Dihydroorotase inhibitor | 0.041 0.037 DBMET01480 0.041 0.037 DB12529 0.049 0.025 DB13526 | DB13526 | |
| 0.038 | 0.136 | 0.069 | Corticotropin releasing factor 2 receptor antagonist | 0.069 0.029 DBMET01480 0.069 0.029 DB12529 0.064 0.039 DB13526 | DB12529 | |
| 0.127 | 0.225 | 0.264 | 5 Hydroxytryptamine 1E antagonist | 0.264 0.06 DBMET01480 0.264 0.06 DB12529 0.181 0.153 DB13526 | DB12529 | |
| 0.03 | 0.129 | 0.062 | Leukotriene antagonist | 0.062 0.048 DB13526 | DB13526 | |
| 0.013 | 0.112 | 0.023 | ICAM 1 antagonist | 0.023 0.016 DB13526 | DB13526 | |
| 0.017 | 0.117 | 0.055 | Sphingosine 1-phosphate receptor 1 agonist | 0.055 0.016 DB13526 | DB13526 | |
| 0.012 | 0.114 | 0.039 | Diamine oxidase inhibitor | 0.039 0.024 DBMET01480 0.039 0.024 DB12529 0.039 0.025 DB13526 | DB13526 | |
| 0.018 | 0.122 | 0.051 | Potassium channel Kv1.3 blocker | 0.051 0.028 DB13526 | DB13526 | |
| 0.023 | 0.127 | 0.043 | Glutamate (mGluR group III) agonist | 0.043 0.03 DBMET01480 0.043 0.03 DB12529 | DB12529 | |
| 0.01 | 0.116 | 0.03 | Peroxisome proliferator-activated receptor delta agonist | 0.03 0.028 DB13526 | DB13526 | |
| 0.053 | 0.161 | 0.138 | Anesthetic local | 0.138 0.055 DB13526 | DB13526 | |
| 0.031 | 0.139 | 0.064 | Epithelial sodium channel blocker | 0.057 0.033 DBMET01480 0.057 0.033 DB12529 0.064 0.024 DB13526 | DB13526 | |
| 0.02 | 0.128 | 0.056 | Sphingosine 1-phosphate receptor agonist | 0.056 0.02 DB13526 | DB13526 | |
| 0.012 | 0.122 | 0.043 | Cholesterol ester transfer protein antagonist | 0.043 0.01 DB13526 | DB13526 | |
| 0.061 | 0.172 | 0.113 | Beta glucuronidase inhibitor | 0.103 0.066 DBMET01480 0.103 0.066 DB12529 0.113 0.053 DB13526 | DB13526 | |
| 0.091 | 0.202 | 0.19 | Hemostatic | 0.19 0.037 DB13526 | DB13526 | |
| 0.026 | 0.137 | 0.046 | Purinergic P2X4 antagonist | 0.046 0.032 DBMET01480 0.046 0.032 DB12529 | DB12529 | |
| 0.005 | 0.118 | 0.023 | Prostaglandin E2 agonist | 0.023 0.017 DB13526 | DB13526 | |
| 0.03 | 0.144 | 0.056 | Botulinum neurotoxin type A inhibitor | 0.056 0.043 DBMET01480 0.056 0.043 DB12529 0.054 0.047 DB13526 | DB12529 | |
| 0.02 | 0.134 | 0.034 | Protein kinase (CK2) beta inhibitor | 0.034 0.021 DBMET01480 0.034 0.021 DB12529 0.033 0.024 DB13526 | DB12529 | |
| 0.008 | 0.122 | 0.028 | Endothelial nitric-oxide synthase inhibitor | 0.028 0.026 DBMET01480 0.028 0.026 DB12529 | DB12529 | |
| 0.102 | 0.216 | 0.315 | Immunostimulant | 0.167 0.141 DBMET01480 0.167 0.141 DB12529 0.315 0.074 DB13526 | DB13526 | |
| 0.019 | 0.135 | 0.046 | Carbonic anhydrase XIV inhibitor | 0.046 0.038 DB13526 | DB13526 | |
| 0.056 | 0.172 | 0.089 | Bromodomain-containing protein 2 inhibitor | 0.089 0.056 DBMET01480 0.089 0.056 DB12529 0.087 0.06 DB13526 | DB12529 | |
| 0.032 | 0.152 | 0.053 | 5 Hydroxytryptamine 7 agonist | 0.053 0.045 DBMET01480 0.053 0.045 DB12529 | DB12529 | |
| 0.018 | 0.139 | 0.064 | Xanthine dehydrogenase inhibitor | 0.064 0.035 DB13526 | DB13526 | |
| 0.007 | 0.132 | 0.027 | CXC chemokine 2 receptor antagonist | 0.027 0.017 DB13526 | DB13526 | |
| 0.044 | 0.169 | 0.071 | Peroxisome proliferator-activated receptor gamma antagonist | 0.071 0.052 DB13526 | DB13526 | |
| 0.113 | 0.239 | 0.258 | Cyclic AMP phosphodiesterase inhibitor | 0.192 0.1 DBMET01480 0.192 0.1 DB12529 0.258 0.06 DB13526 | DB13526 | |
| 0.01 | 0.136 | 0.084 | Kainate receptor antagonist | 0.084 0.009 DB12529 | DB12529 | |
| 0.035 | 0.163 | 0.062 | Aryl hydrocarbon receptor antagonist | 0.06 0.054 DBMET01480 0.06 0.054 DB12529 0.062 0.05 DB13526 | DB13526 | |
| 0.034 | 0.162 | 0.062 | Heat shock protein 90 beta antagonist | 0.062 0.037 DB13526 | DB13526 | |
| 0.018 | 0.148 | 0.038 | NMDA receptor subunit 3B antagonist | 0.038 0.037 DB13526 | DB13526 | |
| 0.033 | 0.164 | 0.072 | Cathepsin G inhibitor | 0.066 0.059 DBMET01480 0.066 0.059 DB12529 0.072 0.051 DB13526 | DB13526 | |
| 0.057 | 0.189 | 0.175 | MAP kinase kinase inhibitor | 0.175 0.039 DB13526 | DB13526 | |
| 0.102 | 0.234 | 0.194 | ATPase inhibitor | 0.173 0.067 DBMET01480 0.173 0.067 DB12529 0.194 0.042 DB13526 | DB13526 | |
| 0.046 | 0.179 | 0.079 | Histamine H2 receptor antagonist | 0.079 0.068 DBMET01480 0.079 0.068 DB12529 | DB12529 | |
| 0.031 | 0.165 | 0.058 | Sphingosine 1-phosphate receptor 1 antagonist | 0.058 0.033 DB13526 | DB13526 | |
| 0.024 | 0.158 | 0.071 | Cyclin-dependent kinase 6 inhibitor | 0.06 0.041 DBMET01480 0.06 0.041 DB12529 0.071 0.03 DB13526 | DB13526 | |
| 0.017 | 0.151 | 0.07 | NMDA 2C receptor antagonist | 0.061 0.044 DBMET01480 0.061 0.044 DB12529 0.07 0.033 DB13526 | DB13526 | |
| 0.026 | 0.161 | 0.084 | Cyclin D1 inhibitor | 0.058 0.047 DBMET01480 0.058 0.047 DB12529 0.084 0.015 DB13526 | DB13526 | |
| 0.018 | 0.155 | 0.057 | MAP3K5 inhibitor | 0.057 0.007 DB13526 | DB13526 | |
| 0.094 | 0.233 | 0.161 | MAP kinase 3 inhibitor | 0.132 0.103 DBMET01480 0.132 0.103 DB12529 0.161 0.052 DB13526 | DB13526 | |
| 0.016 | 0.156 | 0.049 | Thymidylate synthase inhibitor | 0.049 0.029 DBMET01480 0.049 0.029 DB12529 0.048 0.031 DB13526 | DB12529 | |
| 0.027 | 0.167 | 0.053 | Topoisomerase II beta inhibitor | 0.047 0.038 DBMET01480 0.047 0.038 DB12529 0.053 0.029 DB13526 | DB13526 | |
| 0.08 | 0.222 | 0.137 | Thiol protease inhibitor | 0.133 0.09 DBMET01480 0.133 0.09 DB12529 0.137 0.085 DB13526 | DB13526 | |
| 0.037 | 0.178 | 0.09 | Secretase beta inhibitor | 0.09 0.025 DB13526 | DB13526 | |
| 0.055 | 0.198 | 0.147 | Nav1.6 sodium channel blocker | 0.132 0.078 DBMET01480 0.132 0.078 DB12529 0.147 0.058 DB13526 | DB13526 | |
| 0.011 | 0.155 | 0.032 | Retinoid X gamma receptor antagonist | 0.032 0.009 DB13526 | DB13526 | |
| 0.012 | 0.157 | 0.047 | Peroxisome proliferator-activated receptor alpha agonist | 0.047 0.035 DB13526 | DB13526 | |
| 0.031 | 0.179 | 0.085 | Acetylcholine nicotinic antagonist | 0.085 0.049 DB13526 | DB13526 | |
| 0.017 | 0.167 | 0.04 | Liver X receptor alpha agonist | 0.04 0.031 DB13526 | DB13526 | |
| 0.04 | 0.191 | 0.109 | Urease inhibitor | 0.109 0.057 DBMET01480 0.109 0.057 DB12529 0.099 0.068 DB13526 | DB12529 | |
| 0.051 | 0.203 | 0.085 | Potassium channel (Voltage-sensitive) activator | 0.085 0.078 DB13526 | DB13526 | |
| 0.083 | 0.236 | 0.227 | MAP kinase kinase 2 inhibitor | 0.147 0.124 DBMET01480 0.147 0.124 DB12529 0.227 0.066 DB13526 | DB13526 | |
| 0.06 | 0.213 | 0.11 | Phosphodiesterase 6D inhibitor | 0.09 0.075 DBMET01480 0.09 0.075 DB12529 0.11 0.036 DB13526 | DB13526 | |
| 0.062 | 0.217 | 0.101 | Estrogen antagonist | 0.101 0.096 DB13526 | DB13526 | |
| 0.021 | 0.177 | 0.045 | CC chemokine 4 receptor antagonist | 0.045 0.037 DBMET01480 0.045 0.037 DB12529 0.044 0.038 DB13526 | DB12529 | |
| 0.033 | 0.193 | 0.114 | Potassium channel (Ca-activated) activator | 0.082 0.073 DBMET01480 0.082 0.073 DB12529 0.114 0.045 DB13526 | DB13526 | |
| 0.012 | 0.175 | 0.047 | Phosphorylase inhibitor | 0.047 0.032 DB13526 | DB13526 | |
| 0.051 | 0.214 | 0.172 | Adenylate cyclase inhibitor | 0.1 0.085 DBMET01480 0.1 0.085 DB12529 0.172 0.033 DB13526 | DB13526 | |
| 0.021 | 0.184 | 0.065 | 5 Hydroxytryptamine 2A agonist | 0.065 0.042 DB13526 | DB13526 | |
| 0.064 | 0.231 | 0.436 | Neurotrophic factor | 0.436 0.004 DB13526 | DB13526 | |
| 0.032 | 0.199 | 0.118 | Monophenol monooxygenase inhibitor | 0.118 0.063 DB13526 | DB13526 | |
| 0.064 | 0.236 | 0.137 | Acetylcholine M1 receptor antagonist | 0.137 0.088 DB13526 | DB13526 | |
| 0.075 | 0.248 | 0.178 | DNA methyltransferase I inhibitor | 0.145 0.11 DBMET01480 0.145 0.11 DB12529 0.178 0.081 DB13526 | DB13526 | |
| 0.026 | 0.2 | 0.051 | Fatty acid synthase inhibitor | 0.051 0.05 DBMET01480 0.051 0.05 DB12529 | DB12529 | |
| 0.034 | 0.209 | 0.094 | Myeloperoxidase inhibitor | 0.081 0.065 DBMET01480 0.081 0.065 DB12529 0.094 0.042 DB13526 | DB13526 | |
| 0.072 | 0.248 | 0.196 | Hexokinase inhibitor | 0.155 0.073 DBMET01480 0.155 0.073 DB12529 0.196 0.038 DB13526 | DB13526 | |
| 0.063 | 0.242 | 0.128 | Interleukin 8 antagonist | 0.112 0.073 DBMET01480 0.112 0.073 DB12529 0.128 0.052 DB13526 | DB13526 | |
| 0.102 | 0.282 | 0.173 | Lipoxygenase inhibitor | 0.173 0.172 DB13526 | DB13526 | |
| 0.053 | 0.236 | 0.154 | Cytidine deaminase inhibitor | 0.142 0.082 DBMET01480 0.142 0.082 DB12529 0.154 0.072 DB13526 | DB13526 | |
| 0.055 | 0.239 | 0.301 | Psychostimulant | 0.301 0.042 DB13526 | DB13526 | |
| 0.078 | 0.263 | 0.29 | P-glycoprotein inhibitor | 0.29 0.031 DB13526 | DB13526 | |
| 0.06 | 0.246 | 0.174 | Aryl hydrocarbon receptor agonist | 0.174 0.118 DBMET01480 0.174 0.118 DB12529 | DB12529 | |
| 0.136 | 0.324 | 0.499 | Antibacterial | 0.499 0.041 DB12529 0.35 0.102 DB13526 | DB12529 | |
| 0.038 | 0.227 | 0.075 | Sphingosine 1-phosphate receptor antagonist | 0.075 0.057 DB13526 | DB13526 | |
| 0.076 | 0.265 | 0.217 | I kappa B kinase epsilon inhibitor | 0.163 0.106 DBMET01480 0.163 0.106 DB12529 0.217 0.057 DB13526 | DB13526 | |
| 0.004 | 0.197 | 0.03 | Prostacyclin agonist | 0.03 0.006 DB13526 | DB13526 | |
| 0.088 | 0.284 | 0.192 | Calpain inhibitor | 0.192 0.121 DBMET01480 0.192 0.121 DB12529 0.166 0.154 DB13526 | DB12529 | |
| 0.011 | 0.209 | 0.081 | Cannabinoid CB1 receptor agonist | 0.081 0.028 DB13526 | DB13526 | |
| 0.009 | 0.208 | 0.046 | Purinergic P2Y antagonist | 0.046 0.03 DB13526 | DB13526 | |
| 0.021 | 0.221 | 0.073 | Protein kinase C beta inhibitor | 0.073 0.041 DB13526 | DB13526 | |
| 0.037 | 0.238 | 0.079 | Caspase 7 inhibitor | 0.078 0.065 DBMET01480 0.078 0.065 DB12529 0.079 0.064 DB13526 | DB13526 | |
| 0.059 | 0.262 | 0.138 | Pyruvate kinase inhibitor | 0.138 0.127 DBMET01480 0.138 0.127 DB12529 | DB12529 | |
| 0.071 | 0.284 | 0.179 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.179 0.114 DBMET01480 0.179 0.114 DB12529 0.155 0.136 DB13526 | DB12529 | |
| 0.065 | 0.28 | 0.132 | Cyclin-dependent kinase 8 inhibitor | 0.132 0.1 DB13526 | DB13526 | |
| 0.038 | 0.262 | 0.09 | Protein kinase C zeta inhibitor | 0.09 0.065 DB13526 | DB13526 | |
| 0.051 | 0.275 | 0.143 | Antibacterial (Helicobacter pylori) | 0.112 0.094 DBMET01480 0.112 0.094 DB12529 0.143 0.052 DB13526 | DB13526 | |
| 0.017 | 0.245 | 0.054 | Collagenase 3 inhibitor | 0.054 0.05 DB13526 | DB13526 | |
| 0.068 | 0.296 | 0.175 | DNA methylase inhibitor | 0.141 0.126 DBMET01480 0.141 0.126 DB12529 0.175 0.097 DB13526 | DB13526 | |
| 0.015 | 0.245 | 0.054 | Microtubule stabilization | 0.054 0.023 DB13526 | DB13526 | |
| 0.08 | 0.311 | 0.145 | Focal adhesion kinase 2 inhibitor | 0.145 0.139 DB13526 | DB13526 | |
| 0.091 | 0.326 | 0.232 | Calpain 2 inhibitor | 0.232 0.162 DBMET01480 0.232 0.162 DB12529 | DB12529 | |
| 0.052 | 0.289 | 0.111 | Nav1.2 sodium channel blocker | 0.111 0.094 DB13526 | DB13526 | |
| 0.036 | 0.275 | 0.104 | Interleukin 1 beta converting enzyme inhibitor | 0.104 0.053 DB13526 | DB13526 | |
| 0.083 | 0.322 | 0.198 | DNA damaging | 0.174 0.141 DBMET01480 0.174 0.141 DB12529 0.198 0.117 DB13526 | DB13526 | |
| 0.039 | 0.282 | 0.11 | Alkaline phosphatase inhibitor | 0.107 0.105 DBMET01480 0.107 0.105 DB12529 0.11 0.099 DB13526 | DB13526 | |
| 0.037 | 0.28 | 0.091 | GABA receptor agonist | 0.091 0.089 DB13526 | DB13526 | |
| 0.037 | 0.282 | 0.119 | AMP-activated protein kinase stimulant | 0.119 0.049 DB13526 | DB13526 | |
| 0.036 | 0.282 | 0.114 | Protein kinase C gamma inhibitor | 0.095 0.086 DBMET01480 0.095 0.086 DB12529 0.114 0.058 DB13526 | DB13526 | |
| 0.039 | 0.294 | 0.112 | Nav1.3 sodium channel blocker | 0.112 0.083 DB13526 | DB13526 | |
| 0.088 | 0.344 | 0.169 | Histone acetyltransferase inhibitor | 0.169 0.114 DBMET01480 0.169 0.114 DB12529 0.149 0.141 DB13526 | DB12529 | |
| 0.039 | 0.295 | 0.101 | Acetylcholine antagonist | 0.101 0.092 DB13526 | DB13526 | |
| 0.039 | 0.296 | 0.104 | Cholinergic antagonist | 0.104 0.09 DB13526 | DB13526 | |
| 0.037 | 0.295 | 0.107 | Toll-Like receptor 9 antagonist | 0.107 0.101 DBMET01480 0.107 0.101 DB12529 | DB12529 | |
| 0.048 | 0.309 | 0.164 | LIM domain kinase 1 inhibitor | 0.164 0.085 DB13526 | DB13526 | |
| 0.016 | 0.282 | 0.08 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.08 0.071 DB13526 | DB13526 | |
| 0.032 | 0.298 | 0.071 | Phosphodiesterase VI inhibitor | 0.071 0.059 DB13526 | DB13526 | |
| 0.056 | 0.324 | 0.127 | Neuropeptide Y1 antagonist | 0.127 0.107 DBMET01480 0.127 0.107 DB12529 | DB12529 | |
| 0.012 | 0.288 | 0.067 | Prostaglandin-E synthase inhibitor | 0.067 0.053 DB13526 | DB13526 | |
| 0.079 | 0.359 | 0.18 | 12-Lipoxygenase inhibitor | 0.18 0.173 DB13526 | DB13526 | |
| 0.006 | 0.3 | 0.03 | Retinoic acid beta receptor agonist | 0.03 0.005 DB13526 | DB13526 | |
| 0.007 | 0.302 | 0.031 | Retinoic acid gamma receptor agonist | 0.031 0.006 DB13526 | DB13526 | |
| 0.032 | 0.337 | 0.077 | Lipocortins synthesis agonist | 0.077 0.015 DB13526 | DB13526 | |
| 0.026 | 0.336 | 0.089 | Gastric antisecretory | 0.089 0.08 DB13526 | DB13526 | |
| 0.051 | 0.361 | 0.134 | Nitric oxide antagonist | 0.134 0.113 DB13526 | DB13526 | |
| 0.023 | 0.344 | 0.089 | Mediator release inhibitor | 0.089 0.083 DB13526 | DB13526 | |
| 0.022 | 0.347 | 0.148 | Protease inhibitor | 0.148 0.031 DB13526 | DB13526 | |
| 0.069 | 0.41 | 0.185 | Transcription factor STAT3 inhibitor | 0.185 0.156 DBMET01480 0.185 0.156 DB12529 0.178 0.167 DB13526 | DB12529 | |
| 0.016 | 0.356 | 0.085 | MAP kinase kinase kinase inhibitor | 0.085 0.082 DB13526 | DB13526 | |
| 0.012 | 0.365 | 0.123 | Protein kinase (CK2) inhibitor | 0.123 0.046 DB12529 | DB12529 | |
| 0.011 | 0.371 | 0.136 | Protein kinase (CK2) alpha inhibitor | 0.136 0.051 DB12529 | DB12529 | |
| 0.064 | 0.444 | 0.196 | Hypoxia-inducible factor 1 alpha inhibitor | 0.196 0.157 DB13526 | DB13526 | |
| 0.024 | 0.43 | 0.092 | Viral attachment inhibitor | 0.092 0.031 DB13526 | DB13526 | |
| 0.062 | 0.483 | 0.258 | Lipocortins synthesis antagonist | 0.258 0.031 DB13526 | DB13526 | |
| 0.056 | 0.478 | 0.218 | Transcription factor STAT inhibitor | 0.218 0.114 DB13526 | DB13526 | |
| 0.01 | 0.451 | 0.192 | Neuraminidase (influenza) inhibitor | 0.192 0.005 DB13526 | DB13526 | |
| 0.005 | 0.47 | 0.03 | Retinoic acid receptor agonist | 0.03 0.01 DB13526 | DB13526 | |
| 0.039 | 0.514 | 0.241 | DNA directed DNA polymerase inhibitor | 0.241 0.197 DB13526 | DB13526 | |
| 0.003 | 0.483 | 0.024 | Retinoic acid alpha receptor antagonist | 0.024 0.01 DB13526 | DB13526 | |
| 0.008 | 0.497 | 0.068 | Retinoic acid alpha receptor agonist | 0.068 0.007 DB13526 | DB13526 | |
| 0.003 | 0.499 | 0.022 | Retinoic acid receptor antagonist | 0.022 0.01 DB13526 | DB13526 | |
| 0.002 | 0.515 | 0.012 | Retinoic acid receptor gamma antagonist | 0.012 0.008 DB13526 | DB13526 | |
| 0.021 | 0.558 | 0.735 | Hedgehog signaling inhibitor | 0.735 0.004 DB13526 | DB13526 | |
| 0.016 | 0.57 | 0.144 | Anticonvulsant | 0.144 0.136 DB13526 | DB13526 | |
| 0.003 | 0.58 | 0.025 | Retinoid X beta receptor agonist | 0.025 0.011 DB13526 | DB13526 | |
| 0.002 | 0.581 | 0.011 | Retinoic acid beta receptor antagonist | 0.011 0.009 DB13526 | DB13526 | |
| 0.008 | 0.615 | 0.022 | Vitamin D receptor antagonist | 0.022 0.016 DB13526 | DB13526 | |
| 0.003 | 0.636 | 0.077 | Sphingosine 1-phosphate receptor 3 agonist | 0.077 0.009 DB13526 | DB13526 | |
| 0.003 | 0.641 | 0.029 | Retinoid X gamma receptor agonist | 0.029 0.011 DB13526 | DB13526 | |
| 0.005 | 0.647 | 0.174 | Neuraminidase inhibitor | 0.174 0.005 DB13526 | DB13526 | |
| 0.006 | 0.692 | 0.062 | Estrogen-related receptor beta antagonist | 0.062 0.004 DB13526 | DB13526 | |
| 0.036 | 0.748 | 0.188 | Growth hormone agonist | 0.188 0.064 DB13526 | DB13526 | |
| 0.013 | 0.785 | 0.148 | Farnesoid X receptor antagonist | 0.148 0.055 DB13526 | DB13526 | |
| 0.005 | 0.782 | 0.15 | Topoisomerase I inhibitor | 0.15 0.041 DB13526 | DB13526 | |
| 0.007 | 0.794 | 0.374 | Antimitotic | 0.374 0.027 DB13526 | DB13526 | |
| 0.02 | 0.843 | 0.089 | Transcription factor NF kappa B stimulant | 0.089 0.053 DB13526 | DB13526 | |
| 0.013 | 0.854 | 0.061 | Adenine nucleotide translocase inhibitor | 0.061 0.027 DB13526 | DB13526 | |
| 0.013 | 0.863 | 0.11 | Toll-Like receptor 4 antagonist | 0.11 0.055 DB13526 | DB13526 | |
| 0.041 | 0.893 | 0.349 | Interleukin 2 agonist | 0.349 0.046 DB13526 | DB13526 | |
| 0.05 | 0.904 | 0.334 | Peptidyltransferase inhibitor | 0.334 0.015 DB13526 | DB13526 | |
| 0.053 | 0.917 | 0.317 | Calcium channel L-type activator | 0.317 0.143 DB13526 | DB13526 | |
| 0.01 | 0.883 | 0.037 | Glucose-6-phosphate dehydrogenase inhibitor | 0.037 0.027 DB13526 | DB13526 | |
| 0.017 | 0.9 | 0.099 | ABCA1 expression enhancer | 0.099 0.051 DB13526 | DB13526 | |
| 0.022 | 0.922 | 0.382 | Sodium/bile acid cotransporter inhibitor | 0.382 0.023 DB13526 | DB13526 | |
| 0.011 | 0.937 | 0.144 | DNA polymerase I inhibitor | 0.144 0.052 DB13526 | DB13526 | |
| 0.011 | 0.944 | 0.103 | Interleukin 5 antagonist | 0.103 0.038 DB13526 | DB13526 | |
| 0.004 | 0.946 | 0.057 | Sphingosine 1-phosphate receptor 5 agonist | 0.057 0.03 DB13526 | DB13526 | |
| 0.003 | 0.961 | 0.051 | Purinergic P2X3 antagonist | 0.051 0.01 DB13526 | DB13526 | |
| 0.017 | 0.98 | 0.16 | MAP kinase kinase 5 inhibitor | 0.16 0.114 DB13526 | DB13526 | |
| 0.002 | 0.979 | 0.019 | Follicle-stimulating hormone antagonist | 0.019 0.015 DB13526 | DB13526 | |
| 0.003 | 0.983 | 0.476 | Protein kinase (CK1) gamma 1 inhibitor | 0.476 0.005 DB13526 | DB13526 | |
| 0.002 | 0.983 | 0.392 | Protein kinase (CK1) gamma 2 inhibitor | 0.392 0.005 DB13526 | DB13526 | |
| 0.007 | 0.991 | 0.351 | Interleukin 4 antagonist | 0.351 0.006 DB13526 | DB13526 | |
| 0.003 | 0.987 | 0.523 | Protein kinase (CK1) gamma 3 inhibitor | 0.523 0.004 DB13526 | DB13526 | |
| 0.002 | 0.988 | 0.412 | Protein kinase (CK1) gamma inhibitor | 0.412 0.007 DB13526 | DB13526 | |
| 0.001 | 0.989 | 0.189 | Protein kinase (CK1) delta inhibitor | 0.189 0.033 DB13526 | DB13526 | |
| 0.008 | 0.996 | 0.357 | Cyclin-dependent kinase 3 inhibitor | 0.357 0.005 DB13526 | DB13526 | |
| 0.003 | 0.992 | 0.029 | Toll-Like receptor 4 agonist | 0.029 0.014 DB13526 | DB13526 | |
| 0.003 | 0.992 | 0.058 | Prostaglandin F2 alpha antagonist | 0.058 0.05 DB13526 | DB13526 | |
| 0.004 | 0.995 | 0.253 | Growth factor agonist | 0.253 0.03 DB13526 | DB13526 | |
| 0.004 | 0.995 | 0.779 | Immunosuppressant | 0.779 0.004 DB12529 0.349 0.087 DB13526 | DB12529 | |
| 0.004 | 0.996 | 0.151 | MAP3K9 inhibitor | 0.151 0.058 DB13526 | DB13526 | |
| 0.002 | 0.994 | 0.179 | MAP kinase 9 inhibitor | 0.179 0.027 DB13526 | DB13526 | |
| 0.003 | 0.995 | 0.208 | Antiobesity | 0.208 0.199 DB13526 | DB13526 | |
| 0.004 | 0.996 | 0.241 | Hematopoietic | 0.241 0.007 DB13526 | DB13526 | |
| 0.003 | 0.995 | 0.15 | Purinergic P2X2 antagonist | 0.15 0.011 DB13526 | DB13526 | |
| 0.002 | 0.995 | 0.056 | Transforming growth factor beta 2 antagonist | 0.056 0.005 DB13526 | DB13526 | |
| 0.002 | 0.995 | 0.051 | Neuraminidase (Influenza A) inhibitor | 0.051 0.022 DB13526 | DB13526 | |
| 0.001 | 0.996 | 0.078 | Prostaglandin EP2 antagonist | 0.078 0.028 DB13526 | DB13526 | |
| 0.002 | 0.996 | 0.415 | Protein kinase C nu inhibitor | 0.415 0.009 DB13526 | DB13526 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |